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GENERAL INTRODUCTION 
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GENERAL INTRODUCTION 
This study deals with the isolation, structure and function of 
hypocalcin, a hormone present in fish. Hypocalcin has been suggested to 
be homologous to parathyroid hormone (PTH), which was mainly based on 
immunoreactivity. Hypocalcin is the principle factor produced in the 
Stannius bodies (corpuscles of Stannius, CS), small endocrine glands 
present only in holostean and teleostean fish. It is considered the 
major hypocalcémie hormone in these animals. Parathyroid glands are 
present only in terrestrial vertebrates and PTH is the principle 
hypercalcémie hormone. The suggested homology of hypocalcin and PTH, 
therefore, would imply that the hypocalcémie hormone of fish has been 
turned into a hypercalcémie hormone during the water to land transition 
in vertebrate evolution. Such a functional change is only 
understandable when the regulation of calcium metabolism differs 
substantially between aquatic and terrestrial vertebrates, and this 
indeed has been established (1). 
The main calcium regulating organs in terrestrial vertebrates are 
gut, kidney and bone. The gut is involved in the uptake of calcium, 
whereas the kidneys are involved the secretion and reabsorption of 
calcium. Bone is important as a calcium buffer in terrestrial 
vertebrates, since calcium uptake via the food is intermittent. The 
excess of ingested calcium has to be stored in the bone, whereas a 
shortage of calcium uptake can be replenished with calcium resorbed 
from the bone. The deposition and resorption of calcium in bone is 
mediated by osteoblasts, osteocytes and osteoclasts. 
In terrestrial vertebrates endocrine calcium regulation is mainly 
under control of parathyroid hormone (PTH), vitamin-D3-metabolites 
(Vit-D3) and calcitonin (CT). Vit-Dß and PTH are involved in 
hypercalcémie regulation, including an increased calcium uptake by the 
gut, reabsorption via the kidney and resorption from the bone. CT on 
the other hand is, by effecting these targets, involved in hypocalcémie 
control. The interplay of these mechanisms allows very precise 
regulation of blood calcium concentrations in the terrestrial 
vertebrates. (2) 
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Fish are also able to maintain body fluid calcium concentrations 
within narrow limits, and precise regulation of plasma calcium has been 
observed in all species investigated (3, 4). In contrast to terrestrial 
vertebrates, fish take up calcium directly from the water via the 
gills, and only for a minor part via the gut (5). Regulation of the 
uptake of calcium seems, therefore, to occur mainly at the gill level 
(6). Although both gut and kidney are considered as possible targets 
for calciotropic hormones in fish, the literature is scarce and shows 
many contradictions (7-9). Whereas in terrestrial vertebrates the 
importance of bone and bone cells for calcium regulation is undisputed, 
it is still unknown to what extent bone participates in fish plasma 
calcium regulation. There is great diversity in the degree of 
ossification of fish bone. Some species have hardly any mineralized 
tissue, whereas others have an extensively mineralized skeleton (4, 10, 
11). Moreover, some species have cellular bone (with enclosed 
osteocytes) whereas others have acellular bone. Bone resorbing cells 
have been observed in only a few species (1). Furthermore, fish can 
take up calcium continuously from the water and this seems to diminish 
the necessity of a rapidly accessible internal calcium buffer. It is 
therefore unlikely that the role of bone in fish calcium regulation is 
as important as it is in terrestrial vertebrates. 
Because fish live in an aquatic environment with calcium 
concentrations several times lower (freshwater) to several times higher 
(seawater) than that of the body fluids (12) and calcium uptake mainly 
takes place via the gills, fish need appropriate calcium regulating 
mechanisms to maintain blood calcium concentrations within 
physiological limits. It is therefore not surprising that endocrine 
factors involved in calcium regulation in fish are different from those 
of the terrestrial vertebrates. 
Parathyroid glands have never been observed in fish (1). In the 
absence of FTH hypercalcémie control in fish may be achieved by 
prolactin secreted from the pituitary gland (12, 13), although in some 
species hypercalcémie effects of Cortisol have been reported (14). 
However, whereas FTH is a fast acting hypercalcémie hormone in 
terrestrial vertebrates, in fish it takes days to obtain a calcémie 
response after prolactin administration (15). There is another 
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hypercalcémie factor in the fish pituitary, which shows acute effects 
on fish calcium levels (15-17). Unfortunately, the identity of this 
hypercalcémie principle is still unknown. Several Vit-D3-metabolites, 
including the important 1,25(ОН)2-Оз have been demonstrated in fish 
(18). The function of these metabolites in calcémie control in fish 
however, is still in discussion. Calcitonin is probably of minor 
importance in hypocalcémie regulation of plasma calcium levels in fish, 
although salmon calcitonin is known for its clinical applications (19). 
Hypocalcémie control in fish is reported to be achieved by the CS (20). 
Removal of the CS results in extreme hypercalcemia which can be reduced 
by injections of homogenates of the glands (20). On the basis of this 
effect, the hormonal substance present in CS homogenates of some 
teleost fish has been called hypocalcin by Fang and coworkers (21). Ma 
and Copp have isolated a peptide fragment from salmon CS that they 
called teleocalcin (22). The biological activity of this factor, 
however, has not been established beyond doubt. It may be evident that, 
compared to the terrestrial vertebrates, endocrine calcium regulation 
in fish is less well defined. In particular the identity and function 
of the CS hormone is unclear. 
The suggested similarity between hypocalcin and FTH and the 
scarcity of information on identity and function of hypocalcin prompted 
us to test the relationship between the corpuscles of Stannius and the 
parathyroid glands. Furthermore, we were interested in the mechanisms 
involved in the hypocalcémie control of fish. For this reason the 
effects of hypocalcin and FTH were compared in mammalian and fish 
bioassays (Fart I). Additionally, the physiological function of 
hypocalcin was studied by analyzing its effects on gill calcium uptake 
(Part II). 
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THE RELATIONSHIP BETWEEN THE CORPUSCLES OF STANNIUS 
AND THE PARATHYROID GLANDS 
(Part I) 
7 
Chapter 1 
INTRODUCTION 
The question whether there is a relationship between the CS and 
FTH was raised because of the following cosiderations. 
Although parathyroids have never been found in fish, there has 
been interest in the activity of mammalian parathyroid extracts (РТЕ) 
in fish since 1958 (1). Bioactivity of FTH in fish assays might 
implicate the presence of a FTH analogue in fish. Several experiments 
have been reported that show effects of FTH and parathyroid extracts 
(FTE) in fish. After FTH injections in fish, increases as well as 
decreases of plasma calcium levels were shown, and effects on bone 
deposition and as well as on bone resorption were reported (1-7). More 
recently, this work has been resumed. Leung and Fenwick (8) showed a 
hypocalcémie effect of CS extracts in rat. In contrast, Milet and 
colleagues (9) reported a hypercalcémie effect of CS extracts in rat. 
Effects of CS extracts in anurans and in birds were shown to be 
biphasic; within the first 4 hours after administration of CS extracts 
a hypocalcémie effect was observed, which was subsequently followed by 
a hypercalcémie response (10, 11). Thus, effects have been reported of 
FTH in fish and of CS extracts in terrestrial vertebrates, although 
there is no consistency in the results reported. 
Lopez, Milet and colleagues found some indications for a 
structural similarity between FTH and the principle from the CS. They 
tested FTH-antisera on blood plasma of intact eels and in eels after 
the removal of the CS (stanniectomy; STX), and on CS of control and 
СаСІ2 injected eels. Cross-reactivity was found and the CS identified 
as the source of this FTH-like principle (12, 13). However, cross-
reactivity of FTH antisera with head-kidney and pituitary tissue was 
also reported (see 14). Notwithstanding, the immunological similarity 
between the CS principle and FTH was interesting and formed part of the 
basis for the work described in this section of my thesis. 
The mode of control of hormone release from the CS also shows some 
similarity with that of the parathyroids, although the mechanisms 
involved have not been established with certainty. The glands are well 
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vascularized and innervated. The endocrine activity of the CS in vitro 
is increased (directly or indirectly) by elevated blood calcium 
concentrations (15). Aida (16) showed that in vitro the CS respond 
2+ directly to changes in extracellular Ca concentrations. Nervous 
control of hormone release is probably indirectly effected by 
adrenergic control of the vascular flow through the CS (14). 
Parathyroid glands are also well vascularized and innervated, although 
it has been suggested that they are less well innervated than the CS 
(14). Hormone release from the parathyroids is for the larger part 
2+ 
under direct control of the extracellular fluid Ca concentration 
(17). In similarity with the CS, nervous control of hormone release 
seems to be established by adrenergic control of the parathyroid gland 
blood flow (18, 19). 
Both the CS and the parathyroids are involved in the control of 
blood calcium levels. Whereas the parathyroids are involved in 
hypercalcémie control, the CS are involved in hypocalcémie control. 
Removal of the parathyroids from terrestrial vertebrates results in 
hypocalcemia which can be reversed by injections of parathyroid tissue 
extracts (20). On the other hand, STX has been reported by many authors 
and for several fish species to result in hypercalcemia, whereas re-
implantations or injections of crude tissue extracts reverse the STX 
induced hypercalcemia (e.g. 21, 22). Some authors have reported that 
STX also induces changes in blood electrolytes other than calcium. 
These effects, however, may be indirect and result from the rise in the 
plasma calcium concentration after STX (23, 24). 
Similarity between CS and the parathyroid glands is further 
indicated by the presence of immunoreactivity in the CS of eels to 
antibodies raised against secretory protein Ι (ΞΡ-Ι; 25). SP-I and 
related peptides are cosecreted in several types of polypeptide 
producing endocrine cells that are derived from the neural crest, like 
the parathyroids. Although embryological similarity has been questioned 
(14), the presence of an SP-I like protein in the CS suggests that both 
glands have a similar embryological origin. 
These reported similarities between the CS and the parathyroid 
glands prompted us to further investigate the relationship between 
their respective hormones, hypocalcin and PTH. 
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In this part of my thesis it is shown that a CS tissue extract 
contains a principle able to induce bone resorption in a way similar to 
PTH (Ch. 2). This principle (hypocalcin) was isolated and identified 
(Ch. 3) and subsequently shown to be responsible for the PTH-like bone 
resorbing activity of the CS extracts (Ch. 4). Furthermore, hypocalcin 
and PTH were shown to decrease plasma calcium levels in CS deprived 
eels (Ch. 5). Although we observed striking similarities in bioactivity 
between hypocalcin and PTH, the observed difference in amino acid 
sequence between both hormones makes a homology between the CS and the 
parathyroids unlikely. 
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Chapter 2 
PTH-LIKE EFFECTS OF RAINBOW TROUT STANNIUS PRODUCTS 
ON BONE RESORPTION OF EMBRYONIC MOUSE CALVARÍA IN VITRO. 
ABSTRACT 
Products of the Stannius corpuscles (CS) of rainbow trout were tested 
in an established parathyroid hormone (PTH) bioassay involving bone 
resorption in embryonic mouse calvaría. Aqueous extracts from Stannius 
corpuscles (CS-homogenate) showed a bone resorbing activity comparable 
to PTH in 24 h cultures of calvaría, indicated by a dose-dependent 
stimulation of lactate production and of calcium, phosphate as well as 
^-glucuronidase release. Moreover, CS-homogenates induced an increase 
in osteoclastic activity. The PTH-like CS-principle is released during 
in vitro incubations of the glands. These results and the lack of an 
additive effect of CS products and PTH on bone resorption suggest that 
both products activate the same receptor. We hypothesize that the 
hypocalcémie hormone of the CS of fish shares structural resemblance 
with PTH, the major hypercalcémie hormone of terrestrial vertebrates. 
1986 Endocrinology 119:2249-2255 
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INTRODUCTION 
Stannius corpuscles (CS) are small endocrine glands characteristic of 
holostean and teleostean fish. Rainbow trout usually have 2 to 5 ovoid 
corpuscles -located ventrocaudally to the kidney- that vary in diameter 
from 2 to 3 mm (1). For several species it has been reported that two 
different endocrine cell types are present (1-5). There is ample 
evidence that the predominant cell type produces a hypocalcémie factor, 
whereas the second cell type may be involved in sodium and potassium 
regulation (6,7). Effects of CS-products on plasma phosphate, magnesium 
and chloride have been reported, but these effects are usually rather 
small and may result from a disturbance of calcium metabolism (6,7). 
Plasma calcium concentrations rise considerably after stanniectomy 
(STX)j CS implants or injections of CS-extracts completely reverse STX 
induced hypercalcemia (6,9). 
Structural resemblance has been suggested between the hypocalcémie 
factor of the CS and parathyroid hormone (PTH), a hormone considered 
typical for terrestrial vertebrates and absent in fish. Antibodies 
raised against bovine PTH(l-84) showed cross-reactivity with a 
substance in eel blood plasma. This substance disappeared from the 
blood after STX and increased after the infusion of calcium chloride 
(10). Also, secretory substances of the CS cells have been shown to 
cross-react with antibodies raised against bPTH. Overloading the blood 
with calcium chloride resulted in the release of anti-bPTH positive 
secretory material (11). 
The immunological similarities between the CS principle and PTH 
prompted us to investigate a possible relationship in bloactivity 
between PTH and the CS principle. 
In higher vertebrates PTH is known to stimulate bone resorption. 
For rodents the effects of pharmacological doses of PTH on several 
parameters for bone resorption in vitro have been thoroughly 
investigated. Typically, PTH induced bone resorption is accompanied by 
an increased lactate production, as a result of enhanced aerobic 
glycolysis (12). PTH induced bone resorption results from an increase 
in the number of osteoclasts as well as in their bone resorbing 
activity (13). Increased osteoclastic activity and increased release of 
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lysosomal enzymes (.e.g. ß-glucuronidase; 14) as well as the removal of 
bone mineral components (mainly calcium and phosphate; 12) may serve, 
therefore, as parameters for FTH-induced bone resorption. 
We used embryonic mouse calvarla -a tissue with considerable 
PTH-sensitive bone resorbing activity (12)- to characterize the 
bioactivity of the CS principle, using the forementioned parameters. 
MATERIALS AND METHODS 
Calvarium culture technique. 
Calvarla were removed from 18 day old mouse embryos and each 
calvarium was bisected. The left half of one calvarium and the right 
half of the second calvarium and vice versa were fixed at 2 cm from the 
bottom in a 20 ml roller-tube, containing 1 ml of culture medium. The 
tubes were placed in an almost horizontal position in a roller-drum for 
24 h (6-7 rotations per h) (15). The culture medium consisted of 90% 
Hanks'balanced salt solution (Hanks'BSS) and 10Z heat inactivated human 
serum (h-serum). Total calcium and phosphate concentrations in this 
medium were 2.7 and 1.8 raM, respectively. After 24 hours of incubation 
at 37 *C, calvaría were removed from the incubation medium that was 
analyzed within 24 hours for calcium, phosphate, lactate and 
ß-glucuronidase activity. Media were stored, frozen at minus 20 *C; the 
activity of ß-glucuronidase has been reported not to decrease over a 24 
h period (16). 
Hormone administration 
CS homogenate. Stannius corpuscles (a generous gift from Dr N. 
Mayer-Gostan; Laboratoire Jean Maetz; Villefranche-sur-Mer, France) 
were collected from rainbow trout (Salmo gairdneri); whole glands were 
lyophilized and stored at minus 60 *C. Approximately 25 mg lyophylized 
material (equivalent to about 100 mg wet weight CS, the amount of 
tissue obtained from 10 kg trout) was homogenized in 2.5 ml ice-cold 
Hanks BSS. After centrifugation (15 min; at 9.000g) the supernatant was 
diluted to desired concentrations with culture medium, and used within 
2 h. Doses were expressed in mg wet weight of homogenized CS per ml 
calvarium culture medium. 
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Collection of CS products released in vitro. After a minimum 
acclimation period of 2 weeks to Nijmegen tapwater (0.Θ mM Ca), rainbow 
trout were killed, and the CS removed, weighed and rinsed in Hanks'BSS. 
Subsequently they were incubated for 5 hours at 22 'C in Hanks'BSS in a 
shaking water-bath (approximately 10 mg wet weight/150 μΐ Hanks'BSS). 
The incubations were terminated by removal of the corpuscles. The media 
were quickly frozen in liquid N2 and stored at -60 *C, for a maximum of 
7 days. These media were thawed shortly before use and diluted to 
desired concentrations with culture medium. In these experiments only 
the calcium concentration of the medium was determined as a measure for 
bone resorption and an experimental set up was used that allowed paired 
observations as described elsewhere (15). CS doses were expressed as mg 
wet weight -used for incubation- per ml calvarium culture medium. 
Parathyroid hormone. Bovine PTH was purchased from Sigma (TCA 
powder; Cat.no: p0892; 140 IU/rog) and dissolved in 0.005 N acetic acid 
containing IS Fentex-albumin. Solutions of 1 IU/μΙ were stored in 
liquid N2· For the parameters tested in this study no differences were 
observed between the effects of this purified FTH and synthetic 
b-PTH(l-34) (12). Immediately before use, PTH was diluted to desired 
concentrations with culture raediura. Doses are expressed as IU PTH per 
ml of calvarium culture medium. 
Controls. CS-homogenates were heat-treated by a 15 min incubation 
at 100 *C. Bone resorbing activity of such heat-treated homogenates was 
tested using forementioned biochemical parameters. In another set of 
experiments 100 mg tissue samples (wet weight) of rainbow trout liver, 
brain, muscle and trunk kidney were removed and homogenized in 1 ml 
ammonium acetate (50 mM, pH 7.4). After centrifugation (5 min, 9000g) 
supernatants were lyophylized and stored at -20 'C. For experiments the 
samples were dissolved in culture medium to a concentration of 5 mg wet 
weight CS per ml culture medium. Release of calcium and phosphate was 
determined as a measure for bone resorption. 
Analytical methods. 
Medium total calcium content was determined with a commercial 
colorimetrie calcium-kit (Sigma, Cat.no: 586). Inorganic phosphate was 
measured according to the method of Delsal and Manhourim (17). Combined 
calcium phosphate standards (Sigma Cat.no: 360-11) were used as 
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reference. The rae di uni lactate concentration was measured as described 
by Lowry et 31.(18), using an auto-analyzer method (19). Lithium 
lactate (Sigma) was used as reference. The activity of ß-glucuronidase 
in the culture medium was determined according to Mead et al. (20), 
using the conversion of 4-raethyl-umbelllferyl-glucuronide 
(Boehringer-Mannheim) to 4-raethyl-umbelliferyl during a 30 min 
incubation period at 37 'C; 4-methyl-urabelliferyl (BDH) was used as a 
reference. 
Histology. 
For light microscope examinations, calvarla were incubated as 
described above. After a 24 h incubation period, calvarla were fixed in 
phosphate buffered (pH 7.0) 43 glutaraldehyde solution (24 h; 4 'C) and 
decalcified in 52 formic acid, containing 5Z formaldehyde (3 h at 4 
°C), followed by two washes in distilled water. Subsequently, 
acid-phosphatase staining was performed according to Barka and Anderson 
(21). Calvarla were embedded in paraffin; S vm-sections were stained 
with acid haematoxylin. Serial sections from calvarium halves were used 
to quantify osteoclast nuclei; in every fourth section nuclei 
surrounded by acid-phosphatase positive cytoplasm were scored. Results 
are expressed as the mean number of osteoclast nuclei per section ± SEM 
for 3 calvarium halves. 
Statistical analysis. 
Stastistical evaluation was performed by the use of the 
Mann-Whitney U-test (one-tailed). For paired observations Student's t 
test was used. Significance was accepted at Ρ < 0.05. Mean values ± SEM 
are given. 
RESULTS 
Biochemical observations. 
Lactate production. Figure 1 shows the relationship between the 
increase in lactate production by calvarla and the concentrations of 
CS-homogenate or PTH. CS-homogenate and FTH yielded a similar 
activation pattern. Proceeding from an equipotent bioactivity of 10 mg 
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of CS t i s s u e and 0.1 IU PTH, no s igni f icant difference between the 
degree of stimulation by CS-homogenate or by PTH could be observed. At 
the concentrations CS-homogenate tested no maximum lactate production 
was observed. This observation corroborates data that we obtained for 
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Figure 1. Effects of CS-homogenate (· ·) and PTH (0 0) on lactate 
production by 2 calvarium halves, cultured for 24 h. Mean values ± SEM 
are given; for CS-homogenate n-16-24 and for PTH n-4-16. Significant 
stimulation of lactate production occurred at concentrations above 2.5 
mg/mi CS-homogenate or 10"2 IU/ral PTH. 
Figure 2. Lactate production, calcium, phosphate and (î-glucuronidase 
release induced by untreated and heat inactivated CS-homogenate (10 
mg/ral), during a 24 h incubation period. Mean values ± SEM are given; η 
- 8; all differences with the controls are statistically significance. 
the effects of PTH on embryonic mouse calvarla. As much as 1 IU PTH per 
ml is needed to obtain a maximum lactate production (12). Proceeding 
from a similar pattern for PTH and for CS-homogenate induced lactate 
production, it may be calculated that at least 100 mg CS-homogenate per 
ml medium would be required to produce maximum lactate production. 
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Heat treatment of CS homogenates significantly deminished lactate 
production, although the stimulatory effect on lactate production by CS 
homogenates was not completely abolished (Fig. 2). 
Bone demineralization. Figure 3 shows a dose-response curve for 
CS-homogenate and PTH induced calcium release from embryonic mouse 
calvarla. An increase in the amount of CS product resulted in an 
increase of calcium resorption from the bone. As shown in Figure 4, a 
similar dose-response relationship was found for CS-homogenate and 
phosphate release from calvaría. Using calcium and phosphate release as 
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Figure 3. Effects of CS-homogenate (· ·) and PTH (0 0) on calcium 
release from 2 calvarium halves, cultured for 24 h. Mean values ± SEM 
are given; for CS-homogenate n-16-24 and for PTH n-4-10. Significant 
stimulation of calcium release occurred at concentrations above 1.0 
mg/ml CS-homogenate and all PTH concentrations tested. 
Figure 4. Effects of CS-homogenate (· ·) and PTH (0 0) on phosphate 
release from 2 calvarium halves, cultured for 24 h. Mean values ± SEM 
are given; for CS-homogenate n»16-24 and for PTH n-4-16. Significant 
stimulation of phosphate release occurred at concentrations above 1.0 
mg/ml CS-homogenate and all PTH concentrations tested. 
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parameters for bone resorption, again 10 mg CS wet weight could be 
equated with about 0.1 IU PTH. The maximum amounts of calcium and 
phosphate, released by CS homogenate after a 24 h cultivation period, 
were similar to the values observed for the maximum release induced by 
FTH. Half-maximum calcium and phosphate release occurred at about 2.5 
mg CS wet weight/ml, and at about 2.5 ' 10 lU/ml PTH. The value for 
PTH is in good agreement with data from the literature (12). 
Maximum stimulation of calcium and phosphate release was obtained 
by the addition of 0.1 IU PTH or 10 mg wet weight of CS-homogenate 
separately. No further increase in calcium and phosphate release could 
be observed when maximally stimulating doses of CS-homogenates and PTH 
were added together (Table 1). 
Table 1. Calcium and phosphate release induced by maximum effect 
concentrations of CS-homogenate and PTH added separately or together. 
^calcium release ¿phosphate release 
(nmoles) (nmoles) 
Stannius (10 mg/ml) 125 ± 44 (6) 119 ± 28 (9) 
PTH (10"1 lU/ml) 154 ± 33 (9) 91 ± 28 (9) 
Stannius + PTH 147 ± 30 (10) 117 ± 16 (10) 
Mean values ± SEM are given with the number of observations in 
parentheses. No statistical significant differences were observed. 
Heat treatment of CS-homogenates resulted in a complete loss of 
the ability to demineralize the calvaría (Fig. 2). 
Bone resorption in mouse calvarla was also induced by the products 
that are released during in vitro incubation of CS. In Figure 5 the 
dose-response relationship for CS secretory products and calcium 
release is shown. A similar potency to stimulate calcium release was 
found for CS-homogenates and the products released by the same amount 
of tissue during a 5 h incubation period. 
ß-glucuronidase release. Figure 6 shows the dose response 
relationship for ^-glucuronidase release induced by CS-homogenate and 
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Figure 5. Calcium release from 2 calvarium halves, cultured for 24 h, 
induced by CS-products secreted during in vitro incubations. Mean 
values ± SEM are given; paired observations (n-3-6). Stimulation at 
concentrations above 1 mg/ml CS (wet weight used for in vitro 
incubation) are statistically different from the release in the absence 
of hormone. 
Figure 6. CS-homogenate and PTH induced stimulation of the 
(5-glucuronidase activity, during a 24 h culture period. Values ± SEM 
are expressed in Ζ ; release in the absence of hormone was equated with 
100 Z. For CS-homogenate n=16-24 and for PTH n-4-14. The increase in 
the release of ß-glucuronidase activity at concentrations above 1.0 
mg/ml CS-homogenate, and at all PTH concentrations tested are 
statistically different from activity in the absence of hormone. 
PTH. An increasing amount of CS-homogenate resulted in an increasing 
release of ß-glucuronidase. The release of ß-glucuronidase was 
stimulated by PTH over a range of 0.01 to 1 lU/ml. At a concentration 
of 0.3 lU/ml and 1 lU/ml we found 83 ± 22 X and 62 ± 10 X, respectively 
(data not shown in Fig. 5). No dose dependency was observed for PTH 
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1Θ6 ± 37 
37 ± 27 
8 ± 17 
-12 ± 15 
-28 ± 34 
(24) 
(13) 
(13) 
(13) 
(13) 
induced p-glucuronidase release at the concentrations tested. The 
activation pattern of PTH differed from the CS-homogenate activation 
pattern. 
Heat treatment of the CS-homogenates resulted in a complete loss 
of the ability to increase the p-glucuronidase release of calvarla (Fig 
2.). 
Table 2. Calcium and phosphate release induced by tissue homogenates of 
trout CS, kidney, muscle, brain and liver (5 mg per ml). 
5 mg/ml Л Calcium (nmoles) Λ Phosphate (nmoles) 
Stannius 153 ± 19 (23) 
Kidney -22 ± 48 (14) 
Muscle -29 ± 25 (11) 
Brain -62 ± 14 (9) 
Liver -6 ± 15 (13) 
Mean values ± SEM are given with the number of observations in 
parentheses. Asterisks indicate statistical significance. 
Control homogenates. Neither calcium- nor phosphate-release was 
significantly stimulated by tissue homogenates of trout liver, brain, 
muscle and kidney (Table 2). 
Histological observations. 
Osteoclast activation. The addition of CS-homogenate as well as 
of PTH to the incubation medium of the calvaría resulted in a 
significant increase in the number of osteoclast nuclei after a 24 h 
incubation period (Table 3). Doses of PTH and CS-homogenate, giving 
maximum calcium and phosphate release, were tested. At these doses, no 
significant difference was observed between the effect of CS-homogenate 
or PTH. 
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Table 3. Effects of CS-homogenate and FTH on the calvarium osteoclast 
activity. 
number of nuclei per section (in Z) 
Control 100 ± 10 (6) 
CS-homogenate (5mg/ml) 158 ± 22* (3) 
CS-homogenate (10mg/ml) 178 ± 31* (3) 
FTH (1 lU/ml) 183 ± 1 * (2) 
The number of nuclei per section of calvarium halves incubated in 
the absence of hormones is equated with 100 %. Mean values ± SEM 
are given with the number of observations in parentheses. Asterisks 
indicate statistical significance. 
DICSUSSION 
We conclude from the present data that the corpuscles of Stannius 
of rainbow trout produce and secrete a product that resembles FTH in 
its bone resorbing action. Aqueous extracts from CS as well as products 
released by these glands in vitro stimulate bone resorption in 
embryonic mouse calvaría in a way comparable to FTH. Lactate production 
as well as calcium and phosphate release were stimulated 
dose-dependently. The patterns of lactate production and the release of 
calcium and phosphate were essentially similar for CS-homogenate and 
FTH stimulated samples. In this bioassay 100 mg wet weight CS (the 
amount of tissue obtained from 10 kg trout) was found to be equivalent 
to 1 IU FTH. In our assay on the release of ^-glucuronidase, however, 
CS-homogenate proved to be more stimulatory than FTH. The relatively 
weak and dose-independent stimulatory activity of FTH over this 
concentration range is not clearly understood. For a comparable 
bioassay as used in this study, Vaes (14) reported a linear correlation 
between mineral release and ß-glucuronidase release, during 24 to 72 h 
incubations with 0.01 to 1 lU/ml FTH. We found a comparable 
relationship between ß-glucuronidase and phosphate release after 
stimulation with CS-homogenate. For FTH, however, such a relationship 
was not found. Quantitatively, our observations on PTH-induced 
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ß-glucuronidase release (62 ± 10 I increase at 1 IU FTH) compare well 
with those of Vaes, who showed an increase of 75 Ζ after the addition 
of 1 IU PTH (14). The specificity of the bone resorbing effect for the 
CS horaogenates is indicated by the absence of an effect of kidney, 
liver, brain and muscle homogenates in this bioassay. 
Most likely the FTH-like substance of the Stannius corpuscles is 
heat labile. Incubation of CS-homogenate at 100 *C resulted in a loss 
of its ability to stimulate the release of calcium, phosphate and 
p-glucuronidase. The stimulatory effect of CS products on lactate 
production, although significantly diminished by heat treatment, was 
not reduced to controle levels. Apparently, CS-homogenates contain a 
heat labile factor, involved in bone resorption as well as a heat 
stable factor, capable to induce lactate production but independant 
from bone resorption. For this bioassay it has been shown before that 
the lactate production can be stimulated without inducing bone 
resorption (12). 
CS-products increase the number of osteoclast nuclei in mouse 
calvarla. After an incubation period of 24 h, we observed a similar 
increase in the number of osteoclast nuclei in the FTH and the 
CS-homogenate stimulated calvarla, at concentrations that induce 
maximum calcium and phosphate release. The method used in our 
experiments did not allow the determination of the number of 
osteoclasts or number of nuclei per cell separately. Whether the 
increase in the number of osteoclast nuclei is the result of an 
increase in the number of cells or in the number of nuclei per cell 
remains to be established. Rowe and Hausmann (22), however, have shown 
that both an increase in the number of nuclei per cell and an increase 
in the number of osteoclasts (which also results in an increased number 
of nuclei, but may result from a different stimulatory mechanism) may 
result in stimulated bone resorption. Our data with respect to FTH 
corroborate those of Holtrop and coworkers (23) who showed an increase 
in the number of osteoclasts In rat bones after a 24 h stimulation with 
FTH. With respect to CS-homogenates, our _ results corroborate 
histological observations by Milet et al. (24); they reported a 
stimulation of osteoclastic activity 0.5 h after injections of CS 
extracts in rat. 
The CS principle responsible for bone resorption is released 
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during іл vitro incubations of Stannius corpuscles. Recent studies in 
our laboratory give growing evidence for a proteinaceous product, with 
an apparent molecular mass of approximately 25 kDa, as the putative 
hormone of these glands (25). 
Both PTH and the CS-principle exert their bone resorbing action 
via the same pathway; no additive effect was observed when maximum 
stimulating concentrations of PTH and CS homogenste were tested 
together. From the close resemblance between PTH and CS-products in the 
bioassay reported here, we suggest that the Stannius principle 
stimulates bone resorption via activation of the PTH receptor. 
One could argue that the bone resorbing effects of CS homogenates 
reported in this paper originate from an action by prostaglandins. 
However the amount of prostaglandins extracted during our 
homogenization procedure (an aqueous extract) will be very small. More 
importantly, there is no reason to assume that CS contain more 
prostaglandins than any of the other control tissues tested. 
Fontaine and coworkers (26,27) were the first to report -and it is 
generally accepted now- that the CS produce a factor that is 
hypocalcémie in fish. More recently, Lopez and coworkers (10,11) 
suggested, that this hypocalcémie factor was homologous with PTH. This 
suggestion was mainly based on immunocrossreactlvity of the presumed CS 
hormone with PTH antisera (10,11). This immunological resemblance 
should be considered with caution, however. It has been shown that 
antisera against PTH crossreact with products present in other 
endocrine tissues in fish (28). Moreover, not all PTH antisera tested 
cross-react with CS products (29), which indicates that the structural 
similarities between PTH and the CS product is only partial. On the 
other hand, in addition to the immunological resemblances and the 
remarkable similarity in in vitro bioactivity reported here, PTH and 
the putative CS hormone also show similar effects on blood calcium 
levels in vivo. Injections of crude CS-extracts and PTH both elevate 
blood calcium levels in rats (30), and reduce blood calcium levels in 
fish (25,31). All these data strongly suggest that both calcium 
regulating hormones have important structural similarities. An 
attractive hypothesis would be that these structural similarities 
result from phylogenetically conservative aminoacid sequences In the 
biologically active parts of PTH and the CS hypocalcémie hormone. 
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Chapter 3 
IDENTIFICATION OF HYPOCALCIN (TELEOCALCIN) 
ISOLATED FROM TROUT STANNIUS CORPUSCLES 
ABSTRACT 
We have isolated and purified a glycoprotein from the corpuscles of 
Stannius (CS) of trout, which we consider hypocalcin, also called 
teleocalcin, the major hypocalcémie hormone of fish. This product is 
present in relatively large amounts in the CS of several species (i.e. 
European eel, tilapia, goldfish and carp). Hypocalcin is typically 
released from the CS in response to an experimentally induced increase 
of the blood calcium concentration. Ultrastructural observations show 
that after this treatment the type-1 cells, reportedly the hypocalcin 
producing cell type of the CS, are almost completely degranulated. The 
isolated glycoprotein has an apparent molecular weight of 54 kDa as 
determined by SDS-FAGE. This molecule appears susceptible to breakdown 
and is recovered upon concanavalin-A affinity chromatography as a 41 
kDa product. Reducing agents such as mercapto-ethanol or dithiotreitol 
(DTT) employed, e.g. during standard electrophoretic techniques or 
during aminoacid sequence analysis, allow only the recovery of 28 kDa 
or 18 kDa products. Evidence is given that the 54 kDa and 41 kDa 
products are dimeг molecules, with the 28 kDa and 18 kDa products as 
their respective monomeric constituents. The sequence of the first 33 
N-terroinal amino acids of these products and the composition of the 
sugar component are presented. 
1988 General and Comparative Endocrinology 69:19-30 
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INTRODUCTION 
Corpuscles of Stannius (CS) are endocrine glands characteristic 
for holostean and teleostean fish. Since their discovery by Stannius 
(1) a large body of histological research on the CS of many fish 
species has been carried out (2-5). CS produce a factor that that 
probably is the predominant hypocalcémie hormone in fish. Removal of 
the glands results in a strong increase in blood calcium concentration 
(e.g. 6) that is reversed by re-implantations of CS or injections of CS 
tissue homogenates (7-10). Since the gills probably form the major site 
of calcium exchange between fish and water, inhibition of branchial 
calcium uptake may underlie hypocalcémie control (11-13). 
There exists immunological resemblance between the hypocalcémie 
principle of CS and the parathyroid hormone (PTH) of the higher 
vertebrates (14-16). Moreover, the CS hypocalcémie principle has 
similar bioactivity as PTH in mammalian and fish bioassays (Ch.2, 17-
21). Although Wagner et al. (22) reported on a hypocalcémie principle 
isolated from salmon, much work remains on the characterisation and 
mechanism of action of the hypocalcémie principle in fish. 
CS of freshwater and euryhaline species contain two different cell 
types, type-1 and type-2 cells, the latter being absent in most 
seawater species (see review by Wendelaar Bonga and Pang, 5). The fact 
that type-1 cells respond to changes in external calcium has led many 
researchers to postulate that these cells produce the hypocalcémie 
factor (23, 24, 5). 
In 1976 Krishnamurthy (3) suggested, on the basis of histological 
staining by periodic acid Schiff reagent, that the type-1 cells contain 
a glycoprotein. In 1978 Ma and Copp (25) isolated a 3 kDa glycopeptide 
from salmon CS which they called teleocalcin; it was reported to be 
2+ bioactive in vitro, by inhibition of branchial Ca stimulated ATP 
hydrolyzing activity, and in vivo, by its hypocalcémie action in eel 
(26). Pang and coworkers (27), however, concluded from dialysis 
experiments that the bioactive factor of the CS of cod, which was 
called hypocalcin (10), was a product with a molecular weight of at 
least 13 kDa. Fenwick (28) provided evidence that the hypocalcémie 
principle of eels had a molecular weight of at least 10 kDa. In our 
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hands (29) the hypocalcémie principle of tilapia appeared as a 28 kDa 
product when analysed with electrophoretic techniques. Recently, Wagner 
et al. (22) succeeded in purifying and characterising a 39 kDa 
45 glycoprotein from salmon CS which showed inhibition of Ca uptake from 
the water in Juvenile rainbow trout. The group of Milet and coworkers, 
however, postulated the presence of two secretory substances in the CS. 
A 34 kDa peptide, which is called parathyrin of the corpuscles of 
Stannius (PCS), was partly purified and showed hypocalcémie bioactivity 
in stanniectoroized eels (30). A 70-80 kDa glycoprotein showing 
immunocrossreactivity with chromogranin-A antisera and SP-1 (a 
secretory glycoprotein from the parathyroid cells) antisera was 
suggested to be cosecreted with PCS (31, 32). 
In this paper we report on the purification and partial 
identification of rainbow trout hypocalcin. It will be shown that trout 
hypocalcin is a 54 kDa glycoprotein, that is readily released upon 
increased plasma calcium levels. 
MATERIALS AND METHODS 
Stannius tissue homogenates. 
CS were obtained from rainbow trout (Salmo gairdneri), brown trout 
(Salmo trutta), European eel (Anguilla anguilla), tilapia (Oreochromis 
mossambicus), goldfish (Carasslus auratus) and carp (Cyprinus carpio). 
The glands were homogenized in 0.05 M ammonium acetate (pH 7.4) using a 
Potter homogenizer fitted with a teflon pestle. The supernatant 
obtained after centrifugation (5 min; 9000 χ g) was lyophilized and 
prepared for SDS Polyacrylamide gel electrophoresis (see below). 
Calcium injection. 
Rainbow trout and European eel were injected intraperitoneally 
with 0.68 M СаСІ2 solution (100 μΐ per 100 g fish per day) for two 
days. Injections of NaCl solutions of identical molality served as 
controls. Four hours after the last injection blood was collected by 
puncture of the blood vessels of the caudal peduncle using a 
heparinized syringe (Ca -heparin, Radiometer). Subsequently the CS 
were removed and prepared for SDS-PAGE. Blood was analysed for ionic 
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calcium and pH; plasma was analysed for total calcium and osmolality. 
From every fish, part of the CS tissue was fixed and stained for 
electron microscopy as described by Wendelaar Bonga et al. (24). For 
the discrimination between type-1 and type-2 cells structural 
parameters as described by Wendelaar Bonga et al. (24) were used. 
Analytical methods. 
Plasma total calcium and phosphate was determined with a 
commercial calcium-kit (Sigma). Combined calcium/phosphate standards 
(Sigma) were used as a reference. Protein content was estimated with a 
commercial reagent kit (BioRad) using bovine serum albumin (BioRad) as 
a reference. Blood ionic calcium concentration and blood pH were 
determined using an automated ionic calcium analyser (ICA; Radiometer). 
Osmolality was measured using a Roebling micro-osmometer. Distilled 
water and an osmolality standard of 300 mOsmol/kg (Sigma) were used as 
standards. 
SDS-polyacrylamide gel electrophoresis. 
SDS-PAGE was performed according to Laemmli (33) with 15Z 
Polyacrylamide slab gels. To investigate the effects of reducing agents 
on the CS principle, SDS-PAGE was carried out under reducing conditions 
(with mercapto-ethanol) or non reducing conditions (without 
mercapto-ethanol). After fixation of the proteins in the gels by 
methanol and glutaraldehyde, the gels were silver-stained (34). Data 
were quantified by densltometric scanning using a BioRad model 1650 
transmittance scanning densitometer. 
Isolation procedure. 
The isolation of the hypocalcémie principle from CS horaogenates 
was started with concanavalin-A Sepharose-4B column chromatography 
(Sigma ; 1.77 cm2 χ 5 cm). The column was equilibrated with 0.015 M 
Tris-buffer pH 7.4 containing МпСІ2, MgCl2, СаС^, 1 mM each and NaCl, 
1 M (con-Α buffer) according to Roelfzema and Van Erp (35); the flow 
was 15 ml per hour at 4 "C. Lyophilized whole glands of rainbow trout 
were kept in stock at -20 *C. Approximately 100 mg dry weight tissue 
(equivalent to 400 mg wet weight obtained from 40 kg trout) was 
homogenized in 3 ml con-Α buffer with a Potter-type homogenizer fitted 
with a teflon pestle. The supernatant obtained after centrifugation (5 
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min; 9000 χ g) was applied to the column and passed three times through 
the column by short-circuiting the system. Products not bound to con-A 
(residue) were eluted with con-A buffer. The products binding to con-A 
were eluted with 0.3 M σ-methyl-D-glucoside in con-A buffer (isolated 
product). 
Desalting and concentration of eluted material were carried out by 
ultrafiltration (Amicon Ine, USA). Diaflo YM-10 membranes were used for 
the con-A binding material and YM-5 membranes for the residue. 
Ultrafiltration was carried out at 4 *C in 1Θ0 ml stirred cells 
operated at 2.6 MPa N2· After the volume of the eluates had decreased 
to about 10 ml, the ultrafiltration cells were refilled with ammonium 
acetate buffer (0.05 M; pH 7.4) to 1Θ0 ml; this procedure was repeated 
three times. By so doing the con-A buffer was diluted over a thousand 
times. The remaining 10 ml was lyophilized in fractions as required for 
assays, and subsequently stored at -20 °C. SDS-PAGE of the samples was 
routinely carried out as a quality check for product composition. The 
samples containing the presumed hypocalcémie principle proved to be 
pure for at least 9SZ on protein basis. 
HPLC-analysis of the con-A binding fraction was carried out using 
a ChromSpher С1 reversed phase HPLC column (Chrompack). Elution was 
performed with an acetonitrile gradient (0-502) in a buffer containing 
sodium,potasium-tartrate (5 mM; pH 3.0), N32804 (50 mM) and 
butanesulfonic acid (5 mM), the flow was 1 ml/min. Eluted material was 
detected with a Spectraflow-783 absorbance detector at 280 nm. The 
fraction containing a significant amount of protein was collected. 
Freeze drying and TCA precipitation (10 % final concentration) methods 
were used to remove acetonitril and salts from this samples before 
SDS-PAGE was performed. 
Aminoacld sequence analysis. 
Amino acid sequences were determined at the Gas Phase Sequenator 
Facility (Department of Medical Biochemistry, State University of 
Leiden, The Netherlands), The instrument used was an Applied Biosystems 
Model 470A Protein Sequencer, on-line equipped with a Model 120A PTH 
Analyser. Pyridyl-ethylation (36) was carried out for cysteine 
identification. Aminoacid sequence analysis was carried out in the 
presence of the reducing agent dithiotreitol (DTT). 
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Carbohydrate analysis. 
Carbohydrate analysis of the isolated protein was performed at the 
University of Alberta, Department of Physiology, according to Dutton et 
al. (37). Data were quantified by gas liquid chromatography - mass 
spectrometry, using xylose as an internal standard. 
Statistical analysis. 
Data are presented as mean values ± SD. Statistical evaluation was 
performed by the use of the unpaired Student's t-test. Significance was 
accepted at Ρ < 0.05. 
RESULTS 
Identification of the hypocalcémie factor. 
Figs 1 and 2 show typical examples of densitometric scans of 
silverstained products, after SDS-PAGE under reducing conditions, 
present in a crude tissue homogenate of CS of six different teleost 
fish. A product with an apparent molecular weight of approximately 28 
kDa was consistently observed. In Fig 2 it is shown for trout and eel 
that the 28 kDa protein disappeared almost completely from CS tissue 
horaogenates after СаСІ2 injection. Typically, the 28 kDa protein 
constitutes 20Z of the total amount of protein present in the CS tissue 
homogenate of these fish, as derived from analysis of the area under 
the curve of the densitometric scans of the silverstained SDS-gels. A 
densitometric scan after SDS-PAGE of a crude tissue homogenate of NaCl 
injected fish did not differ from a control CS tissue homogenate. 
Electron micrographs (Fig 3 and Fig 4) show that the CS of the 
untreated and the NaCl injected fish contain an abundance of large 
secretory granules. These granules are typical for the type-1 cells 
(З , 23). The cells of the CS of the СаСІ2 injected fish are almost 
devoid of these secretory granules. 
Total plasma calcium levels increased significantly in the СаСІ2 
injected trout and eel (2.47 ± 1.12 to 3.10 ± 0.30 and 3.08 ± 0.16 to 
6.14 ± 0.41 mM, respectively), but were unchanged in the NaCl injected 
controls. Plasma osmolality and blood pH did not change significantly 
in either group. 
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Fig 1. Densitometrie scan of silverstained CS crude homogenates after 
SDS-PAGE of goldfish, carp, tilapia and brook trout. Arrow indicates 28 
± 2 kDa peak for all species. Absorbance is shown as percentage of 
maximum peak hight (-100%) and corresponds to the amount of material. 
Molecular weights (m) of protein markers are given on the horizontal 
axis. 
Fig 2. Densitometrie scan of silverstained CS crude homogenates of 
NaCl (C) or СаСІ2 (E) injected eel and trout after SDS-PAGE. Absorbance 
is shown as percentage of maximum peak height (-100%). Molecular 
weights (m) of protein markers are given on the horizontal axis. 
Fig 5 shows a crude tissue homogenate of trout after SDS-PAGE 
under reducing and non-reducing conditions. Fig 5 (top) shows that this 
product has an apparent molecular weight of 28 kDa only after 
electrophoresis under reducing conditions. Surprisingly, under 
non-reducing conditions this product showed an apparent molecular 
weight of aproximately 5A kDa (Fig 5 bottom). 
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Fig 4. Electron micrographs of CS of NaCl (С) or СаСІ2 (E) injected 
eel¡ С: type-1 cells, with many large secretory granules; E: type-1 
cells devoid of secretory granules (15000 x). 
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Fig 3. Electron micrographs of CS of NaCl (С) or СаСІз (E) injected 
trout; С: type-1 cells, with many large secretory granules; E: type-1 
cells devoid of secretory granules (15000 x). 
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Fig 5. Densitometrie scan of silverstained CS crude homogenates of 
NaCl ( ) and СаСІ2 (··•) injected trout after SDS-PAGE under reducing 
(top) and non-reducing (bottom) conditions. Absorbance is shown as % of 
maximum peak height (-100%). Molecular weight (m) of protein markers 
are given on the horizontal axis. 
Fig 6. Densitometrie scan of silverstained CS crude homogenates ( ), 
residue (...) and isolated principle ( ) after SDS-PAGE under 
reducing conditions (bottom). Isolated principle ( ) after SDS-PAGE 
under non-reducing conditions (top). Absorbance is shown as % of 
maximum peak height (-100Ï). Molecular weights (m) of protein markers 
are given on the horizontal axis. 
Isolation. 
Fig 6 shows a densitometric scan after SDS-PAGE of a crude CS 
tissue homogenate and the fractions after isolation. As shown the major 
constituent of the con-Α binding material has an apparent molecular 
weight of approximately 18 kDa under reducing conditions (Fig 6 
bottom). A minor contamination (with a molecular weight of aproximately 
38 
55 kDa) is observed in this fraction; this contamination is present in 
considerable amounts in the residue. The residue, however, does not 
contain the product present in the isolated fraction (18 kDa), or the 
products that are released from the CS after calcium injections (28 
kDa). Under non-reducing conditions (Fig 6 top) the con-Α binding 
material has a molecular weight of aproximately 41 kDa. 
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Protein analysis of the 
isolated fractions showed that from 
a tissue homogenate of 100 mg dry 
weight of CS (with a protein content 
of 25.3 ± 3.6 mg) 3.07 ± 0.56 mg 
(12%) of isolated product and 6.19 ± 
0.84 mg (24%) of residue protein was 
recovered (n=15). 
Reversed phase HPLC analyses 
performed to purify further the 
con-Α binding material yielded a 
single symmetrical peak at 50% 
acetonitrile, indicating high 
apolarity of the product. A minor 
peak eluted at 35% acetonitrile, 
representing less than 5% of the 
total amount of protein. The 50% 
acetonitril peak has an apparent 
molecular weight of 54 kDa (Fig 7). 
Aminoacid analysis and carbohydrate 
analysis. 
Fig 8 shows the sequence of the 
first 33 N-terminal amino acids of 
rainbow trout isolated con-Α binding 
product. 
No differences in the N-terminal amino acid sequence were observed 
between the 28 kDa and the 18 kDa product. At position 7 consistently 
serine and glutamic acid were detected indicating a microheterogeneity 
in these products. Position 29 could not be identified due to a high 
polarity of this site. This indicates the presence of a sugar residue 
Fig 7 
con-A 
duct. 
HPLC analysis of the 
isolated CS 54 kDa pro-
Gradient (percentage of 
the acetonitril containing sol 
vent B) is shown (...). Elution 
time is given on the horizontal 
axis. Absorbance is shown in %. 
Insert: Densitometrie scan of 
silverstained fraction (indica 
ted in the HPLC chromatogram) 
after SDS-PAGE under non-redu­
cing conditions. Absorbance is 
shown in %. Molecular weight m 
of protein markers are given on 
the horizontal axis. 
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linked to the amino acid chain. Carbohydrate analysis revealed that the 
sugar residue consisted of mannose, galactose and glucosamine, in the 
ratio of 1 : 1 : 2 . The total sugar content made up 121 of the 54 kDa 
protein on a weight basis. 
DISCUSSION 
In this study we show the isolation of a glycoprotein from the CS 
of trout. This product is the hypocalcémie factor of the CS since the 
release of this glycoprotein from the CS is stimulated substantially 
and specifically upon experimentaly induced increase of the blood 
calcium levels. Furthermore it is shown that this product inhibits 
branchial calcium influx in trout wich has been suggested to be the 
main effect of the CS hypocalcémie hormone (39). Because of its high 
molecular weight we will further call this hypocalcémie glycoprotein 
from the CS of trout "hypocalcin". This name was proposed for a CS 
hypocalcémie principle with a molecular weight above 10 kDa by Fang et 
al. (10, 27), whereas the name teleocalcin was first given to a 
hypocalcémie principle with a molecular weight of 3 kDa isolated from 
the CS of salmon (25). 
Hypocalcin is present in relatively large amounts in the CS of the 
6 fresh water species investigated. We conclude that hypocalcin, which 
appears as a 54 kDa band upon SDS-FAGE, is composed of two similar 
subunits that appear as a 28 kDa band upon SDS-FAGE under reducing 
conditions. We further conclude that during isolation using con-A 
chromatography the C-terminal part is split off of the two subunits 
resulting in the appearance of an 18 kDa band upon SDS-FAGE under 
reducing conditions. After SDS-FAGE under non-reducing conditions this 
Ph« -Ser -Ser -Ляп 
A l · 
-Ser 
-Vel 
-Pro-Ser-Aap 
-GI7-C7. - S l y 
Vel 
I h r 
-Ala 
-Phe 
Arg 
-Ala 
-Ста 
-Суа 
-Leu 
-Leu 
- A I D 
-Glu 
- β ί τ 
-Ххя 
Ale 
Ser 
-Leu-
-Thr- Cy. 
18kS· 
-Aep-
1 
1 
1 
1 
28kDe 
Il M M 
File -Ser Ser -Aan 
Ala 
-Ser 
Val 
-Pro 
-Sly 
-Cl II-Aap 
-Суе - S l y 
Val 
-Thr 
-Ala 
-Phe 
-Arg-Cya 
-Ala-Cya 
-Leu 
-Leu 
-Aen 
-Glu 
-Gly 
-Xmc 
Ala 
Ser 
-Leu-
-Thr-
ISkDe 
Cyo-Aep-
/ 1 
1 
1 
2вкІ>а 
i l k H a S4U>· 
Fig 8. N-terminal amino acid sequence of trout {Salmo gairdnerï) 
hypocalcin shown in a diagram of the suggested molecular form of the 
hormone. Position 7 shows two amino acids detected in equal amounts. 
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product appears as a dimer identified as a 41 kDa band. The following 
arguments have led us to these conclusions. 
Corpuscles of Stannius of most freshwater teleost contain two 
different cell types: type-1 cells, which predominate in number and 
contain the large secretory granules, and type-2 cells, which contain 
the small secretory granules (see review by Wendelaar Bonga and Fang, 
19Θ6). In the literature type-1 cells are presumed to contain the 
hypocalcémie principle, since only type-1 cells respond to changes in 
external calcium concentration (38, 24, 23). In the present study we 
showed that an experimentally induced increase in plasma calcium was 
accompanied by massive release of the granules of the type-1 cells, as 
well as by the almost complete disappearance of the 28 kDa product from 
the CS. These observations lead to the conclusion that the isolated 
product represents the hypocalcémie principle of the CS. 
The present observations on the molecular weight of 28 kDa for the 
hypocalcémie principle of trout and eel are in agreement with previous 
reports from our laboratory on the molecular weight of the CS 
hypocalcémie principle of the tilapia Oreochrotnis mossambicus (29). A 
similar 28 kDa product is present in relatively large amounts in the CS 
of all species investigated in the present study. This 28 kDa product 
is synthesized and released during in vitro incubations of tilapia CS, 
as was shown by radioactive amino acid incorporation experiments (29). 
Nevertheless we propose that the hypocalcémie principle of CS is a 54 
kDa glycoprotein. An apparent molecular weight of 28 kDa is, however, 
observed upon SDS-PAGE under reducing conditions. 
How does hypocalcin with an apparent molecular weight of 28 kDa, 
obtained by SDS-PAGE under reducing conditions, relate to the 54 kDa 
protein, obtained by SDS-PAGE under non-reducing conditions? We suggest 
that hypocalcin is composed of two subunits of similar molecular weight 
which dissociate under reducing conditions. The following results 
support this hypothesis. Under reducing conditions the 54 kDa 
hypocalcin appears as a single band of 28 kDa. Furthermore, the results 
of the amino acid sequence analysis also point to the presence of 
almost identical subunits. This amino acid analysis is performed under 
reducing conditions. This implies that amino acid sequence analysis of 
the 54 kDa hypocalcin in fact concerns analysis of the 28 kDa subunits. 
Only a single N-teminal sequence is obtained. An identical sequence is 
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obtained after analysis of the isolated 41 kDa hypocalcin, which 
actually represents the N-terminal sequence of the 18 kDa subunits 
obtained under reducing conditions. However, a consistent 
roicroheterogeneity was observed at position 7 of native 54 kDa as well 
as the isolation variant, the 41 kDa product. We suggest therefore that 
trout hypocalcin consists of two similar subunits that only differ at 
position 7. The high incidence of cysteines (4 in the N-terminal 33 
aminoacids) makes the presence of disulfide bridges between the two 
subunits in the native molecule likely. From their recent work on the 
salmon hypocalcémie principle, Wagner and colleagues (22) also 
concluded that the salmon CS hypocalcémie principle could be composed 
of two subunits. 
Isolation of hypocalcin yields a band of 41 kDa after SDS-EAGE 
under non-reducing conditions, and of 18 kDa under reducing conditions. 
These purified 41 and 18 kDa products are obviously related to the 54 
kDa and 28 kDa products observed in freshly prepared homogenates of CS 
tissue. We suggest that the 18 kDa product is the N-terminal part of 
the 28 kDa product. The following results support this hypothesis. A 
tissue homogenate containing the 28 kDa hypocalcin yields an 18 kDa 
product upon isolation. The residue is consistently devoid of both the 
28 kDa and the 18 kDa product. Furthermore, for still unknown reasons 
in about 1 out of 10 isolations only a 28 kDa product is isolated 
instead of an 18 kDa product and under non-reducing conditions only a 
54 kDa product is obtained instead of a 41 kDa product. Prolonged 
storage of lyophilized CS tissue does result in the disappearance of 
the 28 kDa hypocalcin and the concomitant appearance of an 18 kDa 
product. Although our isolation is carried out at 0 *C we assume that 
endogenous protease activity converts hypocalcin from the 28 kDa to the 
18 kDa product. Perhaps the most convincing evidence for the suggested 
relationship between the 28 and 18 kDa products is the fact that amino 
acid sequence analysis of both purified products reveals identical 
results for the first 33 N-terminal amino acids determined so far (see 
below). Therefore the 18 kDa product must be a N-terminal portion of 
the 28 kDa molecule which is split off during the isolation procedure. 
Hypocalcin in the isolated fraction, obtained by con-A 
chromatography is slightly contaminated, as is shown by SDS-PAGE as 
well as by HPLC analysis. On SDS gel these contaminants (less than a 
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few percent on protein basis) are abundantly present in the residue. 
The homogeneous '50% acetonitril peak' collected by reversed phase HPLC 
analysis appears to be hypocalcin and to be free of contaminants. 
The molecular weight of 41 kDa of the trout isolated product is very 
close to the molecular weight of 39.3 kDa reported for the presumptive 
hypocalcémie factor from the CS of salmon (22). We show here, however, 
that the molecular weight of the 41 kDa product isolated from trout is 
an artefact and that the native product is a molecule of 54 kDa. It is 
possible that the molecular weight of 39.3 kDa reported for the 
hypocalcémie principle of salmon also applies to the N-terminal part of 
a larger molecule. 
The first 33 amino acids of trout hypocalcin show remarkable 
overlap with the first 19 amino acids of the isolated glycoprotein from 
salmon reported by Wagner et al. (22) and the amino acid sequence of 
the CS principle of eel (A. Butkus, personal communication). 
Differences with salmon were found only on positions 3 and 18 where 
serine and alanine are substituted for proline and aspartic acid, 
respectively. For eel differences were found at the same, and five 
additional positions (position, trout/eel; 3, Ser/Ala; 4, Asn/Ser; 18, 
Ala/Glu; 21, Gly/Ser; 22, Thr/Ala; 28, Glu/Asp; 33, Asp/Asn). All 
substitutions could be due to single mutations, except for Ala and Gin, 
position 18 for trout and eel, respectively. For salmon the amino acid 
at position 12 has not been identified. For trout hypocalcin a cysteine 
is found on position 12. For salmon no cysteines were detected (22). 
Therefore, it may well be that salmon hypocalcémie principle has a 
cysteine on position 12, and that differences in the first 19 amino 
acids exist only at positions 3 and 18. 
The amino acid on position 29 could not be determined for our 
isolated trout hypocalcin due to the high polarity of this position. 
This indicates the presence of a carbohydrate chain. Support for this 
hypothesis comes from the finding that position 31 is a threonine, 
since linkage of N-acetyl-glucosamine to aspartic acid (the most common 
binding) requires a sequence Asn-Xxx-Thr/Ser (40). Consequently, this 
would result in an Asn on position 29. For eel, an Asn is also found at 
this position (A. Butkus, personal comunication). Presently, however, 
we can not exclude the possibility of an oligosaccharide 0-1 inked to 
this position, which indicates the presence of a serine or threonine. 
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The ratio of mannose, galactose and glucosamine (1:1:2) that we found 
for trout deviates from the carbohydrate composition of the 
hypocalcémie principle of salmon (22). We found a higher content of 
galactose and did not detect any glucose. 
Lopez, Milet and coworkers suggested that in the CS of eels a 
glycoprotein is cosecreted with a proteinaceous hypocalcémie principle, 
and that this glycoprotein is similar to secretory protein-l (SP-1) 
from the parathyroids of terrestrial vertebrates (30-32). We showed 
however that the isolated glycoprotein of trout is hypocalcémie and 
possesses PTH-like bioactivity (18, 39). In this respect our results on 
trout are in line with those of Wagner et ai. (22) on salmon, who also 
concluded the hypocalcémie product is a glycoprotein. 
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Chapter 4 
RAINBOW TROUT HYPOCALCIN STIMULATES BONE RESORPTION 
IN EMBRYONIC MOUSE CALVARÍA Ш VITRO, IN A PTH-LIKE FASHION 
ABSTRACT. 
Hypocalcin, the major hypocalcémie hormone of fish was isolated from 
trout CS. The bioactivity of hypocalcin was assesed in a FTH-bioassay 
involving bone resorption in embryonic mouse calvaría. Calcium and 
phosphate release and lactate production were stimulated dose-
dependently by hypocalcin. On a molar basis 430 times more hypocalcin 
than PTH was required to obtain an effect similar to PTH in this 
heterologous assy. Hypocalcin did not stimulate the cAMP production 
either in mouse calvaría or in cultured osteoblasts. Hypocalcin 
resembles in this respect PTH molecules shortened or modified at the N-
terminal part, that induce bone resorption without increasing cAMP 
levels. Since hypocalcin and PTH have comparable bioactivity in this 
mammalian bioassay (but also in fish bioassays) we suggest a structural 
similarity between both hormones. We tentatively suggest that both 
hormones act via the same receptors. Since no resemblance exists in the 
primary structures of PTH and hypocalcin, we hypothesize that it is the 
ternary structure of hypocalcin and PTH that shows similarity. 
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INTRODUCTION 
Calcium homeostasis in terrestrial vertebrates largely depends on the 
action of the hypercalcémie parathyroid hormone (PTH) and vitamin-D-
metabolites, and of the hypocalcémie hormone calcitonin (1). Fish, 
like terrestrial vertebrates, regulate blood calcium levels 
efficiently. The endocrines involved in fish calcium metabolism differ 
from those of the terrestrial vertebrates. Calcium regulation in fish 
is dominated by the hypercalcémie action of prolactin or Cortisol (2, 
3) and the hypocalcémie action of the hormone from the Stannius bodies, 
hypocalcin (4). In fish calcitonin seems of minor importance as a 
calcium regulating factor (5). Removal of the corpuscles of Stannius 
(CS) results in an increase in the plasma calcium concentration, that 
may be reversed by CS implants or by injections of CS extracts or 
hypocalcin (Ch.3, 6-8). Hypocalcin that we isolated from trout CS 
(Ch.3, 8), shows substantial similarity for the N-terminal amino acid 
sequence with the hypocalcémie principle of eel (9) and of salmon (10). 
Antigenic resemblance between hypocalcin and PTH is indicated by 
cross-reactivity of antisera raised against bovine PTH (bPTH) with a 
substance in eel blood plasma. This substance disappears from the blood 
after removal of the CS (stanniectomy, STX; 11). Moreover, the same 
antiserum to bPTH cross-reacts with a substance in the CS of the eel 
and this cross-reactivity disappears when the glands are stimulated to 
release their presumed hypocalcémie principle by experimentally induced 
hypercalcemia (12). 
Both PTH and CS extracts decrease blood calcium levels in fish 
(13), and increase blood calcium levels in the rat (14). Recently, we 
advanced biochemical and histological evidence for a similarity in 
bioactivity of CS products and of PTH. Products released during in 
vitro incubation of the CS induced bone resorption in embryonic mouse 
calvarla in vitro, in a way comparable to PTH (Ch.2, 15). We suggested 
that both PTH and the hypocalcémie principle of the CS may act via the 
same receptor. 
PTH-stimulated bone resorption depends on the activity of 
osteoclasts and evidence is accruing that their activity is controled 
via osteoblasts. PTH is thought to act directly on the osteoblast; the 
subsequent signalling from osteoblast to osteoclast may result in bone 
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resorption (16, 17). PTH activity may, therfore, be measured by the 
activity of osteoblasts. Cyclic AMP has long been considered the most 
important second messenger for the action of PTH on its target cells 
(18, 19). However, as originally suggested by Rasmussen and Tenenhouse 
(20), evidence is increasing that also Ca fulfils a second messenger 
function (21, 22, 23, 24). Activaton of either second messenger 
pathway separately may result in bone resorption (21). 
We report here on the effects of trout hypocalcin in a PTH 
bioassay involving bone resorption in embryonic mouse calvarla. We show 
that hypocalcin is the bone resorbing component in a CS tissue 
homogenate. Hypocalcin is shown to stimulate bone resorption 
independently of cAMP production. 
MATERIALS AND METHODS 
Isolation procedure. 
Isolation of hypocalcin from rainbow trout (Salmo galrdneri) was 
performed by Concanavalin-A-Sepharose-4B (Con-Α) affinity 
chromatography as described in detail elsewhere (Ch.3, 8). In short, 
approximately 100 mg lyophilized CS tissue (400 mg wet weight obtained 
from 40 kg trout) was homogenized and applied to a column. Products 
without affinity for Con-Α are referred to as residue proteins. 
Material with affinity for Con-Α is referred to as hypocalcin. 
Sodiumdodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE; 25) 
in combination with a silverstaining procedure (26) was routinely 
performed as a purity check. 
Hormone administration. 
Bovine PTH (bPTH) was purchased from Sigma (TCA powder) and 
dissolved in 0.005 N acetic acid containing 1 Ζ Pentex albumin. 
Solutions of 1 IU/μΙ were stored in liquid N2· Immediately before use 
bPTH was diluted to the desired concentration with culture medium. No 
differences were observed between the bone resorbing effect of this 
Sigma bPTH and synthetic bPTH(l-34). Doses are expressed in IU per ml 
of calvarium culture medium. 
Approximately 100 mg dry weight CS yielded 3.0 ± 0.3 rag purified 
hypocalcin and 4.5 ± 0.1 mg residue proteins. The amount of hypocalcin 
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that was added to the calvarla cultures is expressed in mg BSA equiva­
lents per ml of calvarium culture medium. In accordance with the ratio 
of hypocalcln and residue proteins obtained after isolation (2/3), al­
ways 50 X more residue protein than hypocalcln was added in the assays. 
Calvarium culture technique. 
Calvarla were removed from 18-day-old mouse embryos and each 
calvarium was bisected. The left half of one calvarium and the right 
half of a second calvarium and vice versa were fixed in a roller tube, 
containing 1 ml culture medium (27). The culture medium consisted of 90 
% Hanks' balanced salt solution (Hanks'BSS) and 10 % heat inactivated 
human serum. After 24 h of incubation at 37 *C, calvarla were removed 
from the incubation medium that was subsequently analyzed for calcium, 
phosphate and lactate. 
cAMP production. 
For measurements of the cAMP stimulating activity of PTH and of 
hypocalcln, mouse calvarla were incubated in Hanks'BSS containing 0.5 Ζ 
Pentex albumin. After a 15 min incubation period at 37 'C, calvarial 
cAMP was extracted by ultrasonification in propanol, and measured using 
a phosphodiesterase binding assay (28). Results are presented in pmoles 
cAMP per two calvarium halves produced per 15 min. 
cAMP stimulating activity was also measured in cultured chicken 
OB-cells. To potentiate the сAMP production the adenylatecyclase 
activator forskolin (10 M) was added. The phosphodiesterase inhibitor 
methyl-isobuthylxanthine (MIX; 0.22 mg/ml) was added to prevent 
breakdown of the cAMP produced. Cells were isolated and cultured as 
described elsewhere (27). Experiments were further performed as 
described above. The DNA content of the cell cultures was determined 
according to Karsten and Wollenberger (29). Results are expressed in 
pmoles cAMP per Mg DNA per 15 min. 
Analytical methods. 
Medium total calcium content was determined with a commercial 
calcium-kit (Sigma). Inorganic phosphate was measured according to the 
method of Delsal and Manhourin (30). Combined calcium-phosphate 
standards (Sigma) were used as a reference. The medium lactate 
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concentration was measured as described by Lowry et al. (31) using an 
autoanalyser method (32). Lithium lactate (Sigma) was used as a 
reference. Protein content of the isolated fractions was determined 
with a commercial protein-kit (Biorad) using bovine serum albumin (BSA) 
as a reference. 
Statistical analysis. 
Statistical evaluation was performed by Student's t-test (one-
tailed). Significance was accepted at F < 0.05. Mean values ± SEM are 
given. 
RESULTS 
Bone demineralization. 
The e f fects of hypocalcin, the residue proteins and bPTH on 
calcium and phosphate release from mouse calvarla are shown in figures 
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Figure la and lb. Effects of hypocalcin, residue proteins and bPTH on 
calcium (a) and phosphate (b) release from two calvarium halves, 
cultured for 24 hours. Mean values ± SEM are given (hypocalcin and 
residue proteins η - 8; PTH η - 4). 
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la and lb. Figure la shows that hypocalcin and PTH stimulate calcium 
release dose dependently. Both hormones give a similar activation 
pattern. The residue proteins were without effect. Similar results were 
found for phosphate release (Fig lb). Proceeding from an equipotency of 
0.1 mg hypocalcin and 0.1 IU PTH in this bioassay no significant 
differences between the degree of stimulation by hypocalcin or by PTH 
for both parameters can be observed over a 2 log unit concentration 
range (Fig la & b). 
A tissue homogenate of 100 mg trout CS contains bioactivity equi­
valent to 1 IU PTH (Ch2, 15). The amount of protein of a tissue extract 
of 100 mg trout CS is 4.5 ± 1.6 mg (n-16). Therefore, the specific 
activity of a crude tissue extract (SA
e x t) can be expressed as 1 IU PTH 
activity per 4.5 mg tissue extract protein (SA
e x t» 1/4.5 - 0.22 IU 
PTH/mg protein). The specific 
activity of purified hypocalcin 
(SAjjyp) is 1-00 IU PTH/mg protein. 
According to this bone resorption 
assay than, the purification factor 
for hypocalcin (^Ag^/SAjj-p) is 
1.00/0.22- 4.5 . 
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Figure 2. Effects of hypocal­
cin, residue proteins and bPTH 
on lactate production of two 
calvarium halves, cultured for 
24 hours. Mean values ± SEM are 
given (hypocalcin and residue 
proteins η - 8; PTH η - 4). 
Lactate production. 
The effect of hypocalcin, 
residue proteins and bPTH on lactate 
production in mouse calvarla are 
shown in figure 2. Doses of 
hypocalcin and of PTH that give 
comparable responses when analyzed 
for calcium and phosphate release, 
also give a comparable stimulation 
of lactate production. Proceeding 
from the SA of hypocalcin as 
calculated above on the basis of 
calcium and phosphate release we 
found similar dose response curves 
for hypocalcin and PTH with respect 
to lactate production. 
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Residue proteins which do not stimulate release of calcium and 
phosphate from bone gave a significant and dose-dependent stimulation 
of lactate production. 
cAMP production. 
Table 1 shows that CS tissue extracts, residue proteins and 
hypocalcin have no effect on cAMP production in mouse calvaría, where 
PTH does stimulate cAMP production. No significant stimulation of cAMP 
production in the presence of forskolin was found by hypocalcin. 
Table 1. Effects of CS crude tissue homogenates, hypocalcin, residue 
protein and PTH on cAMP production in mouse calvarla. 
(pmoles/2 calvarium halves) 
control 1.4 ± 0.6 (7) 
CS tissue extract (5 mg/ml) 2.1 ± 1.2 (3) 
residue proteins (600 μg/ml) 2.1 ± 1.8 (6) 
hypocalcin (500 ug/ral) -1.1 ± 1.3 (9) 
CS tissue ext (5 mg/ml + forsk. 10"7 M) 1.4 ± 3.2 (3) 
PTH (.25 lU/ml) 50 ± 11 (7)* 
(.5 lU/ml) 180 ± 8 (7)* 
Calvaría were incubated for 10 min. Mean values ± SEM are given with 
the number of observations in parentheses. Asterisks indicate 
statistical significance. 
Also, hypocalcin was unable to stimulate cAMP production in OB-like 
cells (both in the presence and absence of forskolin). PTH (0.05 IU), 
however, gave a significant stimulation of cAMP production in these 
cells and its effect was potentiated by forskolin (9 ± 1 and 114 ± 21 
pmoles cAMP/pg DNA, respectively). 
DISCUSSION 
From the data presented in this paper we conclude that hypocalcin 
stimulates bone resorption in a FTH-like fashion. Two parameters 
characteristic for PTH-induced bone resorption, viz. calcium/phosphate 
release and lactate production, are stimulated dose-dependently by 
hypocalcin. 
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We previously reported that rainbow trout corpuscles of Stannius 
(CS) produce and secrete a product that resembles FTH in its bone 
resorbing ability in mouse calvarla (Ch.2, 15). The observations 
presented here substantiate and extend our previous report and show 
that a single product in a CS extract, viz. the glycoprotein 
hypocalcin, is responsible for the PTH-like bone resorbing activity. 
A A.5-fold purification calculated from the bone resorbing assay 
is in good agreement with a 4 fold purification that we calculated from 
a fish bioassay involving calcémie responses in eels (data to be 
published elsewhere). The low purification factor indicates that the CS 
store an abundance of hypocalcin. The high degree of granulation of the 
hypocalcin containing cells of fresh water fish (Ch.2, 15) is 
consistent with this notion. 
— 8 
The activity of 1 mg hypocalcin (1.85 ' 10 raol) is equivalent to 
the activity of 1 IU FTH (4.27 " 10"5 mol). On a molar basis then 430 
times more hypocalcin than PTH was necessary to obtain a similar bone 
resorbing effect in mouse calvaría. Although hypocalcin seems rather 
potent in this heterologous FTH-bioassay, PTH proved to be even more 
potent in an in vivo fish bioassay; we calculated that equimolar 
amounts of hypocalcin and PTH have a similar hypocalcémie effect in eel 
(data to be published elsewhere). Apparently, both hypocalcin and PTH 
may evoke physiological responses in a mammalian as well as in a fish 
bioassay. We tentatively conclude therefore, that both calciotropic 
hormones may activate PTH-dependent as well as hypocalcin-dependent 
targets. 
Hypocalcin is able to increase lactate production in mouse 
calvarla. Lactate production may serve as a parameter for FTH induced 
bone resorption since FTH induced bone resorption is always coupled to 
lactate production (27, 33). FTH fragments reported to induce bone 
resorption (21) also induce lactate production (34). Residue proteins, 
which were not able to induce calcium and phosphate release, were also 
able to stimulate lactate production in a dose dependent way. This 
suggests that residue proteins contain aa factor which is capable to 
enhance calvarial metabolism without increasing bone resorption. These 
observations corroborate our previous results where we showed that a CS 
tissue extract contains two products that may stimulate lactate 
production: a factor that stimulates bone resorption and a factor which 
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does not stimulate bone resorption (Ch.2, 15). Although PTH induced 
bone resorption is always coupled to lactate production, lactate 
production is not necessarily coupled to bone resorption (33). 
Therefore, lactate production per se is not an exclusive parameter for 
bone resorbing activity. 
Although cAMP is reported to be an important second messenger for 
the bone resorbing activity of PTH, hypocalcin was, in contrast to PTH 
and despite its PTH-like bone resorbing effects, not able to increase 
cAMP production. However, it has been demonstrated that the bone 
resorbing effect of PTH is not fully dependent on cAMP as a second 
messenger. PTH fragments modified or shortened at the N-terminus induce 
bone resorption without increasing cAMP levels (21). We therefore 
suggest that hypocalcin to some extent resembles PTH but lacks, in 
agreement with the forementioned PTH fragments, that part of the 
molecule that is essential for cAMP production. 
On the basis of the similarities in bioactivity of hypocalcin and 
PTH (N-terminal shortened fragments) in the PTH bioassay as reported in 
this paper and in a previous paper (Ch.2, 15), we suggested that both 
hormones act via the same receptor site. In this case hypocalcin should 
2+ 
stimulate bone resorption via changes in cytosolic Ca , similari to 
what has been shown for shortened PTH fragments (24). Unfortunately, 
2+ tests on the effects of hypocalcin on Ca influx in OB-like cells 
using the Quin2 fluorescence method (24) appeared not to be feasible 
because of the high autofluorescence of hypocalcin. Our former 
observation, however, that hypocalcin (CS tissue extract) increase the 
number of osteoclasts in mouse calvaría (Ch.2, 15) -the increase in 
2+ 
number of osteoclasts is suggeted to be mediated by Ca as a second 
messenger (35)- gives indirect evidence that hypocalcin may induces 
2+ Ca influx in bone cells. In this respect hypocalcin can be a useful 
tool to further investigate the two binding sites of the PTH receptor 
and the relative contribution of both second messengers in the PTH 
induced bone resorbing activity (35). 
Several factors like prostaglandins (36, 37), phorbolesters (38) 
and PTH-like tumor factors (39) may induce bone resorption without 
activating the PTH receptor. One could argue then that the bone 
resorbing activity of hypocalcin also could result from the activation 
of a pathway different from the one activated by PTH. However, several 
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notions are in favor of a common receptor-second messenger pathway 
activated by hypocalcin and PTH. There is a striking similarity in the 
effects induced by both hypocalcin and PTH with respect to the bone 
resorbing activity (including the increase in the number of 
osteoclasts; Ch.2, 15). We have also shown, by testing maximum 
stimulating concentrations of hypocalcin containing CS tissue extracts 
and PTH together, that additive effects of both hormones for bone 
resorption may be excluded (Ch.2, 15). Hypocalcin and the forementioned 
PTH fragments have in common that they induce bone resorption without a 
detectable increase in сAMP production. Furthermore, the similarity 
between PTH and hypocalcin is not restricted to PTH-like bone resorbing 
activity in vitro. CS tissue extracts have been reported to be 
hypercalcémie in rats (14); conversely, PTH and hypocalcin have been 
reported to be hypocalcémie in intact fish (40). We have recently 
confirmed that PTH and hypocalcin exert hypocalcémie effects in 
stanniectomized eels (41). 
The similarity in bioactivity, however, seems not congruous with 
the fact that there is no similarity in amino acid sequence between 
hypocalcin and PTH. Although immuno-crossreactivity has been reported 
between some PTH antisera and the products released by the CS (11, 12), 
the amino acid sequence of hypocalcin (Ch.3, 8-10) shows no similarity 
with PTH (or any other known peptide). Furthermore, whereas PTH is a 
peptide, hypocalcin is a glycoprotein possibly composed of two subunits 
(Ch.3, 8). We postulate therefore that these hormones partially 
resemble each other, not in their primary structure but in their three 
dimensional configuration. This would be a plausible explanation for 
the immunological similarities as well as for the similarities in 
bioactivity of these hormones in homologous and heterologous bioassays. 
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Chapter 5 
HYPOCALCEMIC ACTIVITY OF TROUT AND EEL HYPOCALCIN 
AND OF BOVINE PTH IN STANNIECTOMIZED EELS 
ABSTRACT 
In this paper we show that hypocalcin isolated from trout and eel 
CS as well as bovine PTH (bPTH) exert hypocalcémie effects when 
injected intra-arterially in hypercalcémie stanniectomized (STX) eels. 
Upon injection of both hypocalcins we observe a decrease in blood ionic 
calcium which fully accounts for the decrease in total calcium. 
Injections of bPTH also result in a decrease of total and ionic calcium 
concentrations of the blood. The decrease in ionic calcium upon 
injection of bPTH, however, does not fully account for the decrease in 
total calcium concentration of the blood. Nevertheless, hypocalcin and 
bPTH show striking similarity in bioactivity in stanniectomized eels. 
Some similarity in three dimensional structure of both hormones may 
underlie this phenomenon. 
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INTRODUCTION 
Corpuscles of Stannius (CS) are small endocrine glands 
characteristic for bony fish. Eels have one pair of CS, that is located 
ventrocaudally to the kidney. More than the calcitonin secreting 
ultimobranchial glands, the CS have been suggested to be involved in 
hypocalcémie control in fish (1-3). Removal of the glands 
(stanniectomy, STX) results in an increase in the blood calcium 
concentration, whereas injections of CS homogenates or reimplantations 
of CS correct STX-induced hypercalcemia (1, 4, 5). 
In the literature a variety of products has been reported to be 
secreted by the CS (3, 6-8). However, the main bioactive secretory 
product of the CS seems to be a glycoprotein (Ch.3, 9, 10). This 
glycoprotein has been isolated from salmon CS by Wagner et al. (9) and 
named teleocalcln, whereas we recently have isolated the glycoprotein 
from trout (Ch.3, 10). We have called the principle hypocalcin, the 
name originally proposed by Pang et al. (11) for the active factor of 
the CS. The products from salmon and trout show only small differences 
in molecular weight and substantial similarity in the N-terminal amino 
acid sequence (Ch.3, 9, 10). The N-terminal sequence derived from DNA 
base analysis of the principle of the Australian eel is also similar to 
that of trout and salmon (12). Wagner et al. (9) have shown that the 
isolated salmon principle inhibits Ca uptake in juvenile rainbow 
2+ trout. We showed that trout hypocalcin inhibits branchial Ca influx 
in adult trout (Ch.8, 13). 
Imunological resemblance has been shown between a CS principle and 
the parathyroid hormone (PTH) of the terrestrial vertebrates (14-16) 
and It has been suggested that the CS are homologues of the parathyroid 
glands (17). CS tissue extracts and PTH show similar activities in 
mammals and fish (Ch.2, 14, 16, 17, 18). Wendelaar Bonga et al. (19) 
have shown hypocalcémie activity of bPTH(l-34) in low calcium 
acclimated killifish and tilapia. On the other hand, the latter authors 
have questioned the homology of CS and parathyroid glands on the basis 
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of reported differences in embryological origin (3). Furthermore, 
Butkus and colleagues (12) have shown that there is no similarity in 
the predicted amino acid sequence of eel hypocalcin and PTH. 
In the present study we have isolated a 54 kDa glycoprotein from 
eel CS. We have tested the ability of this principle, trout hypocalcin, 
and of bPTH on their ability to decrease plasma calcium levels in STX 
eels. From a physiological point of view, ionic calcium is more 
important than the total calcium concentration of the blood (20, 21). 
We have therefore monitored the ionic as well as the total blood 
calcium concentration after hormone injections. 
MATERIALS AND METHODS 
animais. 
Trout (Salmo gairdnerí), used for the collection of the CS, with a 
body weight between 200 and 300 g and were obtained from a commercial 
trout farm (Nijmegen, The Netherlands). 
European eels (Anguilla anguilla), of 230-290 g body weight, were 
obtained from several commercial fish mongers. They were collected only 
in the summer; the fish were sexually immature. The eels were 
acclimated to Nijmegen tapwater, for at least 3 weeks but no longer 
than 6 weeks, in 500 1 opaque well aerated fibre-glass tanks. Water was 
filtered by recirculation over charcoal (1000 1/h) and refreshed with a 
constant inflow of tapwater (100 1/h). Total calcium concentration of 
the water was 0.65 ±0.5 mM. Water temperature was between 10 an 12 "C. 
Analytical techniques. 
Plasma total calcium was determined using a commercial calcium 
reagent kit (Sigma). Ionized calcium and pH of whole blood were 
measured within 30 min after sampling in an automated ionic calcium 
analyzer (ICA-1, Radiometer; 22). Protein was measured using a 
commercial protein reagent kit (Biorad). Osmolality was measured in a 
Roebling raicro-osraometer. 
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Isolation of hypocalcin. 
Hypocalcin was isolated as described recently (Ch.3, 10) using 
concanavalin-A (con-Α) affinity chromatography. Material bound to con-A 
consisted for trout as well as eel of a glycoprotein with an apparent 
molecular weight of 41 kDa (hypocalcin). Hypocalcin fractions proved to 
be pure for at least 95 Ζ on protein basis. The material without 
affinity to con-A is referred to as residue proteins and was almost 
devoid of hypocalcin as judged by sodiumdodecylsulphate-polyacrylamide 
gelelectrophoresis (SDS-PAGE) (23) and bioassay (Ch.8, 13). 
Stanniectomy and cannulation. 
Eels were anaesthetized in sodium bicarbonate buffered (pH 7.6) 
ethylaminobenzoate (MS222, 2 g/1). During operation that lasted up to 
10 min fish were kept wet and CS were removed from the kidney via a 
small incision through the body wall and the kidney capsule (2 cm long 
sagittal incision, at the position of the anus; 24). Muscle and skin 
were sutured. The fish were allowed to recover in 200 1 well aerated 
tanks with a constant flow of fresh tapwater (100 1/h). The CS obtained 
from these fish were collected on solid CO2 and used for isolation of 
hypocalcin as described above. 
Ten to twelve days after this operation fish were anaesthetized 
again and the pneuroogastric artery was cannulated according to 
procedures described by Chester Jones et al. (25). They were kept in 
individual opaque polyvinyl tubes with a diameter of 5 cm, perfused 
with running, well aerated tapwater (50 1/h). Cannulas were conducted 
out of these tubes through a longitudinal slot in the tubes and were 
flexibly fixed above water level. This set up allowed free movement of 
the fish and stress free blood sampling. Fish were allowed to recover 
for at least 2 days. The cannulas were used for injection and blood 
sampling. Between these procedures the cannulas were filled with a 
sodium chloride solution (0.6 Z) containing polyvinyl pyrrolidone (0.12 
g/ral) and sodium heparin (500 U/ml), and closed with a metal pin. 
Experimental procedures. 
Six groups of fish were injected at day 15 after STX, with either 
trout hypocalcin, eel hypocalcin, trout residue proteins, eel residue 
proteins, bPTH (Sigma) or vehicle (0.9% saline solution). These 
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injections were immediately followed by an injection of a 500 μΐ blood 
sample which was previously drawn from the fish. 
The amounts of protein injected per 100 g fish were 50 μ& 
hypocalcin and 80 pg residue proteins; these doses equal the amount of 
material obtained from 6 fish. Bovine FTH was injected in a 
concentration of 20 IU per 100 g fish. 
Blood samples were subsequently taken for three days. A blood 
sample of 100 μΐ was drawn to clean the cannula. Subsequently, a 250 μΐ 
2+ blood sample was drawn with a 1 ml syringe containing 10 μΐ of Ca -
heparin (Radiometer). After determination of ionic calcium and pH the 
remaining 140 μΐ blood was centrifuged (1 min at 9000g). Plasma was 
used for determination of the total calcium, osmolality and heamatocrit 
concentration. Two blood samples were taken before injection and eight 
samples over a three day period after injection. The pH, osmolality and 
heamatocrit were measured to check the viability of the eels during 
experimentation. 
Statistical evaluation. 
Mean values ± SEM are given. For statistical evaluation Mann-
Whitney U test (one tailed) was used. Significance was accepted at Ρ < 
0.05. For statistical evaluation of differences between experimental 
and control injected groups and differences between the decrease in 
total and ionic calcium, values obtained at the same time after STX and 
after injection were compared. 
RESULTS 
Stanniectomy of the eels resulted after 15 days in a plasma total 
calcium concentration of 5.71 ± 0.21 raM and a blood ionic calcium 
concentration of 3.21 ± 0.16 raM (n - 50). Before injection, there was 
no significant difference in total or ionic calcium concentration 
between the different treated groups (vehicle treated control group, 
two groups treated with hypocalcin, two with residue proteins and one 
group with bPTH). 
67 
ψ^ -Чц 
.9 
ACa(mM) 
control 
Ca»' 
О 25 5 
t(h) 
2 3 
t (days) 
Fig. 1. The effect of NaCl 
injection (control) on plasma 
total calcium (Ca^0^t ) and 
blood ionic calcium (Ca 2+ 
• ) 
Ca 
in 15 day STX eels. Means ± SEM 
are given. At 
5.58 ± 0.22 mM, Ca 
0.22 mM; n-15. 
t-0: 
2+ tot " 3.12 ± 
After injection of NaCl 
(controls), no significant changes 
in either of the two calcium 
concentrations were observed over 
the three day period the samples 
were taken (Figure 1). The maximum 
decrease was 0.08 ± 0.04 and 0.22 ± 
0.05 mM for ionic and total calcium, 
respectively. 
Injections with trout and eel 
hypocalcin resulted in a decrease of 
total and ionic calcium (Figures 2a 
and 3a, respectively). When injected 
in the same dose the reduction of 
plasma calcium levels was similar 
for both preparations. The blood 
calcium lowering effect started 
within a few hours after injection 
and reached its maximum after 24 
hours. Although after 24 hours the 
calcium concentrations were tending 
upwards, the difference with the 
controls was still statistically 
significant three days after 
inj ection. 
The decrease in plasma total calcium and the decrease in blood 
ionic calcium were similar. The differences between the reduction in 
ionic and total calcium were not statistically significant. 
Injections with residue proteins resulted neither in a significant 
change of total calcium, nor of ionic calcium (Figures. 2b and 3b). 
Injection with bPTH resulted in a decrease of the plasma total 
calcium as well as the ionic blood calcium concentration (Figure 4). 
The decrease in total calcium concentration, however, was more 
pronounced than, and statistically different from, the decrease in 
ionic calcium. 
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Figs. 2a and 2b. The effect of trout hypocalcin (a) and trout CS 
residue proteins (b) on plasma total calcium (Ca t o t, ) and blood 
ionic calcium (Ca 2+ 
At t-0: Ca tot 
(n=5); Ca t o t - 6.26 ± 0.22 mM, 
proteins (n-7) 
) in 15 day „STX eels. Means ± SEM are given. 
3.06 ± 0.37 mM for hypocalcin 
3.07 ± 0.13 mM for residue 
4.62 ± 0.52 mM, Ca 2+ 
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Figs. 3a and 3b. The effect of eel hypocalcin and CS eel residue 
proteins on plasma total calcium (Cat
ot, ) and blood ionic calcium 
(Ca2+, ) in 15 day STX eels. Means ± SEM are given. At t-0: Ca t o t -
5.88 ± 0.28 mM, Ca 2 + - 3.58 ± 0.20 mM for hypocalcin (n-9)·, C a t o t -
5.59 ± 0.37 mM, Ca*'*' - 3.28 ± 0.27 mM for residue proteins (n-10). 
After residue injection the effect on total calcium is only significant 
at t-24 h (0.04 < Ρ < 0.05). 
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The pH was measured for all 
blood samples and did not change 
during the experiments (pH - 7.9 ± 
0.1). Osmolality and hematocrit were 
determined for 5 animals which were 
all diferently treated. No 
significant changes during the 
experiment were observed for blood 
hematocrit (35 ± 12 X) or plasma 
osmolality (289 ± 6 mOsmol/kg). 
Fig. 4. The effect of bPTH (Sigma 
crude extract) on plasma total 
calcium (Ca t o t, ) and blood 
ionic calcium (Ca , - -) in 15 day 
STX eels. Means ± SEM are given. At 
t-0: Ca t o t = 6.47 ± 0.49 mM, Ca
2 +
 -
2.99 ± 0.41 mM (n-4). Decrease in 
ionic calcium did not differ statistically from the decrease in 
controls. Asterisks indicate statistically significant differences 
between the decrease in ionic and total caclium concentrations; 1: Ρ < 
2 3 
t(days) 
0.10, 2: Ρ < 0.06). 
DISCUSSION 
In this paper we show that the glycoprotein isolated from trout 
and eel CS, which we tentatively have named hypocalcin (Ch.3, 10), 
induces a decrease of plasma total calcium in hypercalcémie STX eels. 
Since the CS residue proteins do not show a significant calcium 
reducing activity in contrast to the isolated product, we conclude that 
the isolated glycoprotein may indeed be equated with the hypocalcémie 
principle of the CS for which Pang et ai. (11) have proposed the name 
hypocalcin. The decrease in calcium concentration after a single 
injection with hypocalcin was maximal one day after injection and 
persists for at least 3 days. This is in line with observations on eels 
that it takes at least some days before plasma calcium levels become 
elevated after removal of the CS (e.g. 5, 26). 
The glycoproteins we isolated from trout and eel CS have an 
apparent molecular weight of 41 kDa. In a previous study we have found 
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the same molecular weight for trout hypocalcin (Ch.3, 10). This value 
is in good agreement with the apparent molecular weight (39 kDa) of the 
hypocalcémie principle isolated from salmon CS (9). However, as we 
concluded in a recent paper (Ch.3, 10), the isolated 41 kDa product 
probably forms the N-terminal part of a 54 kDa product. The latter was 
considered to be the native hypocalcin molecule. 
Hypocalcin isolated from CS of both trout and eel and injected in 
the same dose in the eel, results in an effect similar for both 
hypocalcins, which indicates a low species specificity of hypocalcin. 
This supports observations of Pang et al. (11, 27) who have shown a 
decrease of blood calcium concentrations in low calcium acclimated 
killifish after injection with CS crude tissue homogenates of a 
variety of fish species. 
Infusion of both hypocalcins results in a decrease in blood ionic 
calcium which fully accounts for the decrease in total calcium. This 
contrasts with the suggestion of Bailey and Fenwick (26) that the CS 
stimulate the binding of ionic calcium to plasma proteins, without 
affecting total plasma calcium concentration. Our results show that 
upon hypocalcin treatment of hypercalcémie STX eels normal ionic 
calcium levels are restored, without changes in the other blood calcium 
fractions. We therefore conclude that the hypocalcin regulates the 
blood ionic calcium fraction. This is probably effected by inhibition 
2+ 
of gill Ca influx. We have shown that hypocalcin injections reduce 
2+ 2+ 
branchial Ca influx without affecting Ca efflux, which results in a 
net loss of calcium via the gills (Ch.8, 13). 
From a physiological point of view, the blood ionic calcium 
concentration may be more important than the blood total calcium 
concentration. This has been extensively shown for many higher 
vertebrates. For instance, McLean & Hastings (20) have elegantly 
2+ demonstrated that a frog heart reacts as a Ca selective electrode. 
There is, however, a limited number of reports on ionic blood calcium 
homeostasis in fish. Recently Andreasen (21) has reported that the 
blood ionic calcium level in trout is kept constant in different stress 
situations. In intact eels CS extracts caused a decrease of the ionic 
calcium fraction, without effecting other parameters (28). 
Infusion of bPTH also results in a decrease of total and ionic 
calcium concentrations of the blood. The dose used (20 IU/100 g fish) 
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results in a response not significantly different from the effect 
induced by 50 μg hypocalcin/100 g body fish. This means that on a 
molecular basis about equal amounts of FTH and hypocalcin are required 
to obtain a similar calcium lowering effect. The presence of 
parathyroid glands has never been reported for fish, whereas CS have 
never been observed in terrestrial vertebrates. The effects of PTH in 
teleost fish has attracted attention since 1958, when Budde tested PTH 
in the guppy and showed effects on bone mineralization (29). Effects of 
CS extracts on terrestrial vertebrates have been reported by Milet et 
al. (14), who have shown an increased calcium release from rat bones in 
vitro. In 19Θ0 Milet et al. have reported on the immunological 
resemblance between FTH and a principle from the CS (15). This inspired 
further study of the similarity between PTH and hypocalcin. Wendelaar 
Bonga et al. (19) have recently shown a hypocalcémie effect of FTH in 
killifish and tilapia adapted to low calcium water. We have reported 
that CS tissue homogenates as well as the isolated glycoprotein induce 
bone resorption in embryonic mouse calvarla in vitro (Ch.2, 18). These 
observations may point to a homology between the CS and the parathyroid 
glands as has been suggested by Milet, Lopez and coworkers (15, 17). 
However, although both hypocalcin and PTH reduce plasma calcium levels 
in fish, there is some difference between the effect of hypocalcin 
treatment and PTH treatment. Whereas the reduction of plasma calcium by 
hypocalcin is mainly effected by a change in ionic calcium, bPTH 
induces a decrease in ionic calcium that does not fully account for the 
decrease in total calcium. Apparently, both ionic and protein bound 
calcium are decreased by PTH. This suggests that hypocalcin and FTH may 
act, possibly partially, via different mechanisms. Hypocalcin is 
reported to inhibit gill Ca2+ influx without affecting Ca2+ efflux, 
which results in a net loss of calcium via the gills (Ch.S, 13). In 
addition to the inhibition of gill Ca2+ influx (15), PTH may act on 
bone mineralization in fish (29). 
The supposed homology between PTH and hypocalcin has been doubted 
recently. Wendelaar Bonga et al. (19) reviewed reports indicating that 
the parathyroids and the CS have a different embryological origin. 
Furthermore, the N-termlnal amino acid sequence for salmon and trout 
hypocalcin (Ch.3, 9, 10) as well as the predicted total amino acid 
sequence of eel hypocalcin as reported by Buskut et al. (12) show no 
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similarity with the aminoacid sequence of FTH. This is also at variance 
with the supposed homology between both products. Nevertheless, there 
is a striking similarity in bioactivity between FTH and hypocalcin, in 
mammalian as well as fish studies. Some similarity in the three dimen-
sional structure of both hormones may underlie this phenomenon. 
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Chapter 6 
INTRODUCTION 
As stated before, corpuscles of Stannius (CS) are without question 
involved in hypocalcémie control. The mechanisms which underlie this 
hypocalcémie control, however, are ill-defined. In terrestrial 
vertebrates calcium homeostasis of the blood is mainly controlled by 
the regulation of intestinal calcium uptake and by the buffering 
activity of the bone. Calcium regulation in fish is particularly 
interesting because of the intense interaction of these organisms with 
their aquatic environment. Calcium regulation in fish is probably fully 
dependent on the regulation of the exchange of calcium with the water. 
Fish gills contain very efficient mechanisms for the regulation of 
calcium exchange between the ambient water and the body fluid, which 
probably are hormonally controlled (1). The aim of this study was to 
investigate the function of the corpuscles of Stannius (CS) in the 
hormonal control of this exchange. The involvement of the CS in this 
process is indicated by studies of Milet and Fenwick (2, 3). The 
results of these studies were contradictory, however. The isolation of 
hypocalcin from the CS as described in part I enables us to study more 
specifically the mechanisms involved in hypocalcémie control in fish. 
The following considerations were the basis for this study. 
Fontaine (1964) was the first to show that the CS are involved in 
calcium regulation (4). Removal of the glands (stanniectomie; STX) from 
the eel resulted in a very pronounced increase of plasma calcium 
levels. Hypercalcemia after STX has since been reported for several 
other species, e.g. killifish, goldfish, sticklebacks and tilapia, 
although for technical reasons most of the experiments reported were 
carried out on eels (5-8). Re-implantation of CS or injections of CS 
tissue homogenates reversed STX induced hypercalcemia (11-12). 
The source of calcium responsible for the hypercalcemia after STX 
was unclear. STX of eels adapted to low calcium water resulted in a 
reduced hypercalcemia, whereas fish adapted to acalcemlc water did not 
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develop hypercalcemia (e.g. 6, Θ). This indicates that the ambient 
water is the source of calcium responsible for this effect. 
Contradictory results, however, have been reported and bone has also 
been suggested to be the source (13, 14). The observation that CS 
homogenates reverse STX induced hypercalcemia does not necessarily 
imply that the CS have a hypocalcémie function in intact fish. True 
hypocalcémie activity of CS extracts in fish, i.e. a decrease of plasma 
calcium levels in intact fish, has been reported only twice. In these 
experiments hypocalcemia could, however, only be evoked with CS 
extracts in fish adapted to low calcium water and fed a low calcium 
diet (8, 15). Histological examination of the CS of fish adapted to 
high or low calcium environments revealed that the glands are more 
active in calcium rich water (e.g. 16-17). This is a further indication 
that the glands are involved in the regulation of the calcium exchange 
between water and fish. 
The kidney, gut and gills have been suggested to be involved in 
the control of calcium handling between water and fish. A decrease of 
urinary calcium concentrations following STX has been reported (18), 
although contradictory results have also been shown (13). Injections of 
CS extracts decreased intestinal calcium absorbtion via the gut (19). 
The latter effect, however, may be of minor importance for total 
calcium uptake from the environment, since calcium uptake mainly takes 
place via the gills (1). For this reason the gills have been considered 
the most important target for hypocalcin (1). Gills from STX eels 
displayed a considerably higher net calcium uptake than the gills of 
sham operated eels (2, 20). In another study, gill arches from 1 week 
STX eels showed an increased influx of calcium and a decreased efflux 
of calcium (3). Furthermore, it was shown that perfusion of gill arches 
with CS extracts resulted in a decrease of the calcium influx and an 
increase of the calcium efflux. The calcium lowering effect of CS 
tissue extracts injected in STX eels has therefore been suggested to 
originate from a decreased calcium uptake from the water (3). However, 
under control conditions as wel as STX conditions the net flux of 
calcium was negative, which makes these experiments difficult to 
interpret. 
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Considering the gills as the major target organ for hypocalcin, 
what mechanisms then are involved in calcium handling of the gills and 
how may these mechanisms operate? It has been reported that the 
chloride cells in the branchial epithelium are responsible for the 
calcium uptake by the gills (21). A model for gill calcium handling in 
fresh water fish has been originally postulated in our laboratory for 
tilapia (22). More recently this model has been extended to trout (23). 
2+ It proposes that the Ca efflux is passive and paracellular, and 
controlled by the trans-epithelial potential (TEF) and the chemical 
2+ gradient for Ca between extracellular fluid and the ambient water. 
2+ Ca influx on the other hand is thought to be transcellular. It 
involves a passive entry of calcium at the apical membrane of the 
chloride cells from water to cytosol via an electro-chemical gradient. 
Calcium transition from cytosol to the blood is achieved by an ATF 
driven calcium pump located at the basolateral membrane. On the basis 
of this model hypocalcémie control in freshwater fish can be effected 
2+ 2+ 
by increasing Ca efflux or by decreasing Ca influx across the 
2+ branchial epithelium. An increase of Ca efflux can be realized by 
increasing the permeability of the paracellular branchial route of the 
2+ 2+ 
epithelium. Decrease of Ca influx may involve an inhibition of Ca 
2 + 
entry into the chloride cells and/or an inhibition of the Ca pump. 
In this part of my thesis the participation of the CS and more 
specifically of hypocalcin in the hypocalcémie regulation in fish is 
studied. It is shown that hypocalcemia after STX is a prolonged 
phenomenon indicating that the CS are the only endocrine glands 
involved in hypocalcémie control. Results obtained with injections of 
CS extracts in STX eels show that the CS are involved in the regulation 
of ionic calcium (Ch.7). Furthermore, it is shown that injection of 
2+ hypocalcin in trout inhibits specifically and acutely Ca influx 
2+ 
across the gills without effecting Ca efflux; a hypothesis for the 
mechanism of action of hypocalcin at the cellular level is presented 
that is based on the above described model (Ch.8). Experimentally 
increased blood calcium levels evoke the release of endogenous 
2+ hypocalcin and inhibits branchial Ca influx which is further evidence 
for the hypocalcémie function of the CS (Ch.9). 
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Chapter 7 
EFFECTS OF STANNIECTOMY AND INJECTIONS OF STANNIUS CORPUSCLE EXTRACTS 
ON TOTAL AND IONIC CALCIUM LEVELS IN THE EEL 
ABSTRACT 
Removal of the corpuscles of Stannius (stanniectomy, STX) from 
freshwater eels increased the total and ionic calcium concentrations in 
the blood. The increase in ionic calcium starts later and is relatively 
smaller than that the increase of total calcium which leads to a 
decrease of the ratio of the blood ionic over plasma total calcium 
2+ 
concentrations (Ca /Ca t o t). Apparently, the increase in ionic calcium 
2+ 
was limited by enhanced Ca binding to plasma proteins. 
Notwithstanding, blood ionic calcium levels increased more than two 
fould. Hypercalcemia reached a maximum between 18 and 22 days after 
STX. Although calcium levels tended to decrease thereafter, they still 
were significantly elevated 40 days after STX. Intra-arterially 
injected crude tissue extracts of CS of eel, trout or salmon in eels 15 
days after STX caused a decrease of ionic and total calcium levels. The 
reduction of the total calcium concentration was almost completely due 
to a reduction of ionic calcium. We conclude that the CS produce the 
main hypocalcémie hormone in eel which is involved in the regulation of 
the ionic calcium level of the blood. 
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INTRODUCTION 
In a variety of teleost species removal of the CS (stanniectomy; 
STX) resulted in a rise of plasma total calcium (e.g. 1-8). In several 
of these studies, the subsequent hypercalcemia was found to be 
transient; normocalcemla was observed again within 5 to β weeks after 
STX (2, 9, 10). The development of hypercalcemia was dependent on the 
water calcium concentration (e.g. 6, 9, 11, 12). In acalcemlc water no 
rise in plasma calcium concentrations was observed after STX (13). 
Injection of CS homogenates (1, 4, 7, 14) or reimplantation of the 
corpuscles (11, 13) reversed STX induced hypercalcemia. 
Beyond doubt the CS are of major importance for the regulation of 
plasma calcium; yet, their effect on plasma ionic calcium has received 
little attention. Using a frog heart, McLean and Hastings (15) were the 
first to show that it is the ionic fraction of plasma calcium which is 
physiologically important. For trout it has recently been shown that 
ionic calcium levels are kept constant under different stress 
situations (16). Reports on ionic calcium levels in fish, however, are 
limited. In humans, plasma total calcium can be divided in a protein-
bound (38Z) and an ultrafiltrable or dialytic fraction (62Z). The 
latter fraction consists of complexed calcium and ionic calcium which 
represent 10Z and 52Z of plasma total calcium, respectively (17). The 
amount of calcium associated with the blood cells as compared to the 
amount of calcium in the plasma is negligible (16) and, therefore, the 
concentrations of the calcium fractions in the plasma reflect the 
concentrations of the respective fractions in whole blood. 
According to Chan and Chester Jones (1Θ), the plasma ionic calcium 
fraction in eels is rather constant and comparable with the ionic 
calcium fraction found in mammals; in the freshwater eel about 54Z of 
the total plasma calcium is in the ionic form. The concentrations of 
2+ plasma ionic calcium reported range from 1.3 to 1.6 mM Ca (3, 5, 1Θ). 
This relatively large variation may well be due to the techniques 
available at that time to measure ionic calcium rather than reflect 
true biological variation. 
Only two reports evaluated plasma ionic calcium concentrations 
after STX. Chan (3) gave provisional evidence for an increase in plasma 
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ionic calcium in 14 days SIX Japanese eel and Fenwick (5) reported an 
increase of ionic calcium concentrations two weeks after SIX in the 
North American eel. Chan (3) concluded that the initial rise in plasma 
total calcium following STX was mainly due to a rise of plasma ionic 
calcium. In these experiments ionic calcium levels, but not total 
calcium levels, returned to normal approximately 2 weeks after STX. The 
decrease in ionic calcium level was suggested to result from an 
increase in plasma calcium binding proteins, since total calcium 
concentrations stayed elevated up to 5 weeks after STX. Fenwick (5), on 
the other hand, reported that the increase in total calcium after STX 
exceeded the increase in ionic calcium; both calcium fractions were 
still elevated 3 weeks after STX. Recent reports on plasma ionic 
calcium levels after STX and subsequent replacement therapy are 
lacking. The techniques to measure blood ionic calcium concentrations 
have recently been improved, and therefore we re-evaluate in this 
report the effects of STX on blood ionic and total calcium levels in 
the eel. Furthermore, we show the effects of injections of CS extracts 
in STX eels on blood ionic and total calcium concentrations. Parameters 
2+ 
crucial for the evaluation of ionic Ca concentrations in the blood, 
viz. blood pH and plasma protein content were determined as well. 
MATERIALS AND METHODS 
Animals. 
Immature European eels (Anguilla anguilla), ranging in body weight 
from 200 to 350 g, were obtained from commercial fish dealers in the 
Netherlands. Upon arrival in the laboratory the fish were kept in 300 1 
aerated tanks supplied with running Nijmegen city tapwater (total 
calcium between 0.6 and 0.7 mM). The fish were not fed. The temperature 
of the water was between 11 and 13 *C. Fish were acclimated for at 
least 3 weeks but for no longer than 6 weeks before experimentation. 
Freshwater rainbow trout (Saimo gairdneri), weighing around 250 g 
were obtained from a commercial trout farm (Beek, The Netherlands) and 
were used for collecting CS. 
Lyophylized CS of coho salmon (Oncorhynchus kisutch) were a 
generous gift from Prof. J.C. Fenwick (University of Ottawa, Canada). 
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Surgery. 
For surgery the eels were anaesthetized in sodium-bicarbonate 
buffered ethylaminobenzoate (MS 222, 2.5 g/1, pH 7.8). Eels were 
stanniectomized or sham-operated as described by Leloup-Hatey (19). 
Muscle and skin were sutured carefully and the fish were allowed to 
recover in 100 1 tanks containing aerated running tapwater. The CS of 
the STX fish were collected on solid CO2 for subsequent preparation of 
CS extracts. 
The pneumogastric artery was cannulated as described by Chester 
Jones and colleagues (20). Cannulated eels were kept in individual 
opaque polyvinyl cylinders supplied with running tapwater as described 
before (21). The set-up allowed free movement of the eels and 
relatively stress-free blood sampling. 
Preparation of CS extracts. 
Lyophylized CS of eel, trout or salmon were homogenized in ice 
cold saline (0.6Z sodium chloride), with a Potter type homogenizer. The 
supernatant obtained after centrifugation of the homogenate at 9000 χ g 
(5 min) was used for injection. For eel and salmon an extract of 1,0 mg 
dry weight CS material was injected per 100g fish; for trout an extract 
of 0.75 mg dry weight CS material per 100 g fish was used. Injection 
volume was 200 μ1/100 g fish. Saline injections served as control. 
Experimental protocol. 
Stannlectomy. Serial blood samples of the eels were taken over a 
period of 17 days maximally. To cover a period of 40 days, three groups 
of 16 eels each were used to study the effect of stannlectomy in time. 
From each group half of the eels was stanniectomized and the other half 
sham-operated. The three groups were cannulated 2 days before, and 11 
and 26 days after STX or sham-operation, respectively. Blood samples of 
200 μΐ were taken once a day using a 1 ml syringe containing 5 μΐ of 
calcium heparin (Radiometer); sampling started 2 days after cannulation 
and lasted 15, 17 and 12 days for each group, respectively. In a 
separate experiment a single blood sample was taken by cardiac puncture 
from 6 fish, 40 days after STX, to evaluate possible effects of the 
cannulation and blood sampling procedure on plasma calcium 
concentrations. 
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Hormone injections. CS extract of eel, trout and salmon was 
injected via the cannula. Before injection a 500 μΐ blood sample was 
taken, of which 200 μΐ was used for plasma analyses. The remaining 300 
μΐ was re-injected immediately following the injection of the CS 
extract. Eight 200 μΐ blood samples, were taken with a 1 ml syringe 
containing 5 μΐ calcium heparin (Radiometer) over a 3 days period after 
injection. 
Analytical techniques. 
Blood samples were analyzed for ionic calcium and pH within 15 min 
after sampling using an automated ionic calcium analyzer (ICA-1, 
Radiometer). Blood was sampled from fish kept in water of 12 °C while 
ionic calcium was determined at 37 °C (the ICA-1 have a fixed 
2+ 
measurement temperature). The overall temperature effect on Ca levels 
in human blood is an increase of ± 0.002 mM/*C (22). Assuming a change 
in ionic calcium of 0.002 mM/"C in eels, we calculated that the 
increase in temperature from 12 to 37 *C results in an overestimation 
of blood ionic calcium with 0.05 mM. 
The blood remaining after ionic calcium analysis was centrifuged 
(1 min at 9000 χ g) and plasma was analyzed for total calcium using a 
commercial calcium-kit (Sigma). Combined calcium-phosphate standards 
(Sigma) were used as reference. 
Plasma osmolality was measured with a micro-osmometer (Roebling) 
using distilled water and a 300 mOsmol/kg standard (Biorad) as 
reference. 
Plasma protein content was determined using a commercial calcium-
kit (Biorad). Bovine serum albumin protein standard (Biorad) was used 
as a reference. 
Statistics. 
The data are presented as means + SEM. The Mann Whitney У-test 
(one-tailed) was used for statistical evaluation. Significance was 
accepted at Ρ < 0.05. To evaluate effects of STX on blood parameters, 
values of STX-eels were compared with the corresponding values of the 
sham-operated eels. To evaluate the effects of CS extract injections, 
values of the CS extract injected eels were compared with the 
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corresponding values of the saline injected eels. Effects are presented 
as the change in plasma total calcium or in blood ionic calcium levels 
relative to these calcium levels before injection. 
RESULTS 
The changes in blood ionic and plasma total calcium after STX are 
shown in Figure 1. The average ratio of ionic calcium over total 
2+ 
calcium (Ca / C atot) i n eei-s stanniectomized for 15 days or longer was 
0.49 ± 0.03. When compared to controls, STX caused an increase in total 
as well as in ionic calcium. The increase in plasma total calcium was 
evident within the first day after injection and reached a maximum of 
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Fig 1. Effect of stanniectomy (STX) and sham operation (control) on the 
blood total (—) and ionic calcium ( — ) concentration of eels. Values 
are presented as means ± SEM (η - 8). Asterisks indicate blood total 
and ionic calcium concentration determined in non-cannulated eels from 
a single blood sample taken by cardiac puncture. 
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approximately 7 mM between 1Θ and 22 days after STX. Blood ionic 
calcium levels became elevated only 6 days after STX and reached a 
maximum of approximately 3 mM within the same time period. The rise in 
total calcium surpassed the rise in ionic calcium. This resulted in a 
2 + 
significant decrease of the ratio Ca /Ca t o t to 0.40 ± 0.04. Total and 
ionic calcium concentrations tended to decrease 22 days after STX, but 
were still significantly higher than those measured in sham-operated 
eels. 
At day 40 after STX, blood ionic and plasma total calcium 
concentrations did not differ significantly from the corresponding 
calcium concentrations determined in blood samples taken by cardiac 
puncture from non-cannulated and non-sampled STX eels. 
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Fig 2a. Effect of saline injections on blood total (—) and ionic 
calcium (—) concentrations in eels 15 days after stanniectomy. Values 
presented as means + SEM (η - 18) are shown as differences compared to 
pre-injection levels. 
Fig 2b. Effect of eel CS extract injection on blood total (—) and 
ionic (—) calcium concentrations in cannulated eels 15 days after STX. 
Values, presented as means ± SEM (η =• 11) are shown as differences 
compared with pre-injection values. 
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Saline injections did not result in a significant change of either 
of the two blood calcium concentrations (Fig 2a). Injections of CS 
extracts of eel, of trout and of salmon in 15 days SIX eels resulted in 
a significant decrease of plasma total and blood ionic calcium levels 
(Fig 2b,c,d). At the time of injection, 15 days after STX, total and 
ionic plasma calcium levels did not differ significantly between the 
four treatment groups. The average pre-injection values were 5.77 ± 
0.20 for total and 3.03 ± 0.15 mM for ionic calcium. A maximum decrease 
of total and of ionic calcium concentration was observed 1 day after 
injection, whereupon calcium concentrations returned to pre-injection 
levels. The decrease in ionic calcium accounted completely for the 
decrease in total calcium. No significant differences were observed 
between the decrease in total calcium and the decrease in ionic 
calcium. 
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Fig 2c and d. Effect of injections of trout (b) and salmon (c) CS 
extracts on blood total (—) and ionic ( — ) calcium concentration in 
cannulated eels 15 days after STX. Values, presented as means ± SEM (η 
« 11), are shown as differences compared with pre-injection values. 
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None of the treatments, either STX or replacement therapy effected 
hematocrit, blood pH, plasma protein content or plasma osmolality. The 
blood pH varied between 7.85 and 7.95, plasma protein concentrations 
was 40 ± 5 mg/ral, and plasma osmolality was 289 ± 7 mOsmol/kg (n - 7). 
DISCUSSION 
Removal of the CS from fresh water eels caused a marked increase 
in plasma total calcium levels. In this respect our data confirm 
earlier reports on eels and other teleosts (1-5, 8, 23, 24). The 
hypercalcemia observed after STX is extreme and a unique and 
interesting phenomenon. To our knowledge no other calciotropic 
endocrine gland has been described of which the removal results in such 
an extreme response. 
In the present experiments plasma calcium levels were measured 
over a 40 days period after STX. Plasma calcium levels tended to 
decrease but remained elevated until day 40. Blood samples from non-
cannulated STX eels confirmed that the persistence of the hypercalcemia 
was not due to the cannulation or disturbance caused by the repetitive 
sampling procedure. Our data contrast with those of others who reported 
that the elevated plasma calcium levels in STX eels decrease 
significantly or even become normal again {e.g. 3, 10, 25). This 
discrepancy may be caused by differences in experimental conditions 
(e.g. the calcium level of the water). Unfortunately, in most reports 
on STX the time span of the measurements was too short or too few 
calcium measurements were done to evaluate restoration of blood calcium 
levels. 
How does STX influence blood ionic calcium levels? We observed 
that the blood ionic calcium level, in contrast to the plasma total 
calcium concentration, did not rise within the first days after STX. 
Furthermore, after STX the ratio of ionic calcium over total calcium 
(Ca /Catot) decreased by about 20%: the protein bound calcium 
2+ 
concentration increased by about 0.7 mM. Apparently most of the Ca 
entering the fish during the first days after STX is buffered by 
2 + 
enhanced Ca binding to plasma proteins. This interpretation is in 
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line with observations of Chan (3), who found that ionic calcium 
returned to normal before total plasma calcium concentrations 
2+ decreased. He suggested that an increase in Ca binding to plasma 
protein, brought about by an increase in the amount of plasma proteins, 
was responsible for the decreased ratio of ionic calcium to total 
calcium. However, we did not observe a significant change in the plasma 
protein concentration. When hypercalcemia has reached its maximum, the 
concentration of calcium bound to plasma proteins (40 rag/ral) has 
increased from 1.25 mM ([Catot]-2.5mM; [Ca
2
*]-!.25raM) to 4 mM 
([Catot]-7mM; [Ca ]-3mM). This implies the binding of about 0.10 mmol 
calcium/g protein, which corresponds to the calcium binding of plasma 
proteins reported for humans (0.12 mmol calcium/g protein; 27). 
In the present experiments changes in blood pH never exceeded 0.1 
pH unit. It is important to keep in mind that changes in blood pH may 
effect the ionic calcium concentration. In human whole blood an 
increase of 0.1 pH unit (in the pH range 7.0 - Θ.3) results in a 
decrease of ionic calcium of approximately 0.06 mM (2Θ, 29). Assuming 
that the same relation holds for eel blood we conclude that pH related 
effects on blood ionic calcium concentrations are negligible in our 
experiments. 
Injection of homogenates of CS from eel, trout and salmon in STX 
eels resulted in a decrease in total calcium concentration which 
corroborates previous reports on the injections of CS extracts in STX 
fish (e.g. 1, 7) and is very similar to the decrease we observed after 
injections of purified trout and eel hypocalcln (Ch.5). The present 
data show that the decrease in total calcium was completely accounted 
for by the decrease in ionic calcium. This clearly indicates that the 
CS are involved in regulation of ionic calcium. If hypocalcln mainly 
controls plasma ionic calcium one could argue that removal of the CS 
should initially have caused an increase in ionic calcium fraction. 
After STX, only the protein bound fraction of calcium had increased and 
later on the increase in protein bound calcium surpassed that in plasma 
ionic calcium. We suggest, however, that this phenomenon reflects the 
calcium buffering capacity of plasma proteins, which appears to be 
large and may buffer ionic calcium levels under normal conditions. This 
ionic calcium binding capacity of plasma protein may obscure the 
effects on blood ionic calcium levels after removal of the CS. 
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It has been suggested that an increased release of calcitonin by 
the ultiraobranchial glands may redress STX induced hypercalcemia (10, 
24), although no evidence has been presented so far. According to 
previous reports (3, 9, 10) it takes at least 5 weeks before plasma 
calcium levels return to normal whereas in our experiments plasma 
calcium levels remained elevated for at least 6 weeks. Assuming that 
the ultimobranchial glands are indeed involved in hypocalcémie 
regulation in fish, we may conclude that the capacity of calcitonin to 
decrease plasma calcium levels in STX eels is very small compared to 
that of the CS hormone. The present data show that injection of CS 
extracts in STX eels decrease plasma calcium levels within hours. 
Transplants of CS in STX fish correct the hypercalcemia within days 
(13). Furthermore, their is no consensus in the literature on the 
function of calcitonin in calcium regulation in fish. In most 
experiments, calcitonin exerts only minor hypocalcémie effects, if any 
(26). We conclude therefore that the ultimobranchial glands are of 
minor importance for hypocalcémie regulation and that no other 
hypocalcémie hormone than that of the CS effectively controles plasma 
calcium levels in eel. 
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Chapter β 
HYPOCALCIN FROM STANNIUS CORPUSCLES INHIBITS 
GILL CALCIUM UPTAKE IN TROUT 
ABSTRACT 
Bidirectional whole body flux and branchial calcium influx were 
measured in freshwater rainbow trout. Intra-arterial injections of 
homogenates of Stannius corpuscles (CS) as well as of a 54 kDa isolated 
2+ product (hypocalcin) exerted an inhibitory effect on whole body Ca 
2+ influx, but did not effect Ca efflux. Hypocalcin was more effective 
2+ in reducing Ca influx in trout acclimated to low-calcium freshwater 
than in fish from normal-calcium water. We conclude that the isolated 
product (hypocalcin) represents the hypocalcémie principle of the CS. 
Similar doses of hypocalcin caused quantitatively similar decreases in 
2+ Ca influx In vivo and in the isolated perfused head preparation. This 
indicates that the gill forms the principle target for hypocalcin in 
trout. The branchial transepithelial potential did not change during 
hormone treatments. A possible mechanism of hypocalcin action is 
suggested. 
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INTRODUCTION 
Teleost fish such as trout are able to regulate their blood 
calcium levels efficiently (2, 11)· It is well known that fish absorb 
calcium directly from the water and that this uptake route can account 
for their entire calcium requirement (5). The gill is the major site of 
calcium exchange between water and fish and, therefore, the gill plays 
a predominant role in the maintenance of the fish's calcium balance (4, 
5, 11). One may reason, then, that the gill will be the primary target 
for calciotropic hormones in fish (4). 
An important calciotropic factor in fish is the hypocalcémie 
principle from the corpuscles of Stannius (CS) (see ref. 22 for a 
recent review). The mechanisms of action of the CS principle are less 
well known, although the gill has been anticipated as one of its target 
organs (11). In isolated perfused eel gill preparations from 
2+ 
stannlectomized fish, an increase in Ca uptake was demonstrated (3, 
2+ 16). Perfusion of CS tissue homogenate caused a reduction of Ca 
uptake (10, 17). 
Recently, we have reported on the isolation and identity of a 54 
kDa product of trout CS (Ch.3, 9). Injection of this principle in 
hypercalcémie stannlectomized eels results in a decrease of plasma 
calcium levels (unpublished results). We have called this principle 
hypocalcin, the name proposed by Fang et al. (12) for the hypocalcémie 
principle of the CS. Here we will demonstrate that hypocalcin exerts an 
inhibitory control on the branchial calcium influx in trout that may 
account for the hypocalcémie action of this hormone. Since it was shown 
that the hypocalcémie action of the CS principle is notable only when 
it is injected into fish adapted to low-calcium water (21), we have 
2+ 
examined its effect on whole body Ca in- and efflux in fish 
acclimated to both normal- and low-calcium freshwater. To establish the 
2+ 2+ 
relative importance of the gill for whole body Ca flux, Ca influx 
also was determined in an isolated head-gill preparation. 
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MATERIALS AND METHODS 
Animals 
Trout (Salmo gairdneri) used for collection of CS and isolation of 
hypocalcin were purchased from a commercial trout farm (The 
Netherlands). The fish used for (in vitro) branchial flux experiments 
(173 ± 6 g; n-19) were acclimated to Nijmegen tap water as described in 
detail by Verbost et al. (18). 
Trout used for (in vivo) whole body Ca flux experiments (183 ± 4 
g (SEM) body weight; n-158) were obtained from a commercial dealer 
(Ontario, Canada). The fish were acclimated for at least 3 weeks to 
dechlorinated Ottawa tap water containing (mM): Ca (0.5), Cl (0.1), 
Na + (0.1), К* (0.02); this water is referred to as normal-calcium 
water. A group of fish were acclimated to low-calcium water, for at 
least 3 weeks. Low calcium water was prepared by titrating 
2+ demineralized water with CaClj-Zt^O to achieve a final Ca 
concentration of 0.04 mM. The Cl", Na* and K + concentrations were 
adjusted to the levels of normal-calcium water. Our set up allowed a 
constant flow of low-, or normal-calcium water through 1000 liter fibre 
glass tanks. Water temperature was 15 ± 3 *C and the water pH varied 
between 6.3 and 7.4. The photoperiod was 12 hours of light alternating 
with 12 h of darkness. Fish were fed daily to satiation with commercial 
trout pellets. 
Analytical methods. 
Water and plasma total calcium contents were determined with a 
commercial calcium-kit (Sigma). Combined calcium-phosphate standards 
(Sigma) were used as reference. Protein content was measured with a 
commercial reagent kit (BioRad) using bovine serum albumin (BioRad) as 
45 a reference. Ca contents of water samples and of plasma samples were 
determined after addition of Scinti Verse II (Fisher) by liquid 
47 
scintillation analysis. Ca contents of water and plasma samples were 
determined by gamma-ray spectrometry. 
Isolation of hypocalcin. 
Hypocalcin was isolated as we recently described (Ch.3, 9), using 
concanavalin-A (con-Α) affinity chromatography. Material bound to con-A 
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consisted of at least 98 Ζ of a 54 kDa glycoprotein, which we named 
hypocalcin. The material without affinity to con-Α (crude CS homogenate 
minus hypocalcin) is referred to as residue proteins and was devoid of 
hypocalcin as judged by SDS-gelelectrophoresis. 
2+ Determination of whole body Ca flux. 
Catheterisation. Fish were anaesthetised in sodium bicarbonate 
buffered (pH 7.4) ethylaminobenzoate (MS222; 0.1 g/liter). During 
operations, that lasted up to 10 min, fish were kept wet and the gills 
were irrigated with MS222-containing water. Dorsal aortic 
catheterisation was subsequently performed using standard techniques. 
Catheters were filled with slightly modified Cortland saline containing 
10 U/ml ammonium heparin and were closed with a stainless steel pin. 
Fish were allowed to recover on the operating table by irrigation of 
the gills with plain water. Next, they were left for at least 24 hours 
prior to experimentation in individual flux boxes supplied with running 
normal- or low-calcium water. 
Experimental procedures. Whole body flux rates were determined 
using catheterised fish kept in 3 liter opaque Perspex boxes. At the 
start of an influx experiment, water flow through the boxes was 
discontinued and *5Ca was added to the water (5 χ IO5 Bq/liter; ICN 
Canada). Efficient mixing of the Ca with the water was assured by 
vigorous aeration of the flux boxes. After a 4 hour exposure period the 
fish were killed with an overdose of MS222 (0.8 g/1). Next, the fish 
were rinsed in tap water (1 min) and transferred for 3 min to water 
containing 10 mM СаСІ2 to exchange Ca adsorbed to the integumental 
surfaces. To determine total body Ca activity, fish were 
microwave-cooked (1.5 min) and homogenized in a commercial blender with 
65Z body weight of distilled water. Quintuple homogenate samples 
(approximately 0.5 g weighed to the nearest 3 decimals) were dissolved 
at 60 *C overnight in 2 ml of tissue solubiliser (NCS; Amersham). 
Subsequently, the samples were neutralized with glacial acetic acid; 5 
45 
ml of distilled water was added and the Ca activity determined. 
For efflux experiments, fish were injected {via their catheter) 
with 2.22 χ 106 Bq of 4 5Ca in 0.6 % NaCl (vol - 1 ml), 24 h before the 
start of the flux period. Ten min before the start of an experiment, 
water flow through the boxes was discontinued and Ca appearance rate 
in the water monitored (see below). After a flux period of 4 hours, the 
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Ca-containing water was replaced by tracer free water until Ca 
reached background levels. Subsequently, a second 4 h flux period was 
performed. The first flux measurement served to establish individual 
control values; the second flux period was used to determine the 
effects of vehicle or hormone treatment. 
Flux determinations were performed according to Flik et al. (5) 
and Ferry & Wood (14). For influx measurements we assumed a constant 
Ca accumulation rate by the fish for at least 4 h. Flik et al. (5) 
45 
showed that in tilapia, the Ca accumulation rate under comparable 
45 
conditions was constant for that time period. Water Ca specific 
activity (SA) did not decrease significantly over the 4 h flux period. 
45 For efflux determinations a constant Ca tracer appearance rate in the 
water for at least 4 h (measurements were performed every 15 min) for 
control as well as hormone-treated fish was observed (r0 » 0.999, 
significance of the slope Ρ < 0.01). Renal calcium excretion was either 
45 
constant or, when intermittent, did not influence water Ca specific 
45 
activity since no fluctuations in Ca appearance rate in the water 
were observed. A 24 h period of internal Ca distribution was 
sufficient to ensure a constant plasma Ca SA (< 5 Ζ change) during 
the flux period. 
Product administration. All injections (200 μΐ) were given 
intra-arterially via the catheter at t-0 of the flux period. Three 
types of treatments were given: a) crude CS tissue homogenates, b) 
hypocalcin, and c) residue proteins. The amounts of protein injected 
per 100 g fish were 235 pg CS tissue homogenate, 50 yg hypocalcin and 
100 pg residue; these doses equal the amount of material obtained from 
3.75 (crude tissue homogenate) and 6.5 fish of similar body weight, 
respectively. Cortland saline injections served as controls. 
Blood and water sampling. For influx as well as efflux 
measurements 500 μΐ blood samples were withdrawn via the catheter 
immediately before hormone injection (t-0) and upon completion of the 
flux experiment (t-4 h). During influx experiments 5 ml water samples 
were taken at t-15 min and at the end of the flux period (t-4 h). For 
efflux determinations, water samples were taken at the start, middle, 
and at the end of the flux period (t- 0, 2 and 4 h, respectively). 
Blood samples were centrifugea in heparinized 1.5 ml tubes. Plasma (100 
μΐ) and water (5 ml) samples were analysed in triplicate for Ca 
101 
specific activity (SA). 
2+ 45 
Calculations. Influx of Ca was calculated from the total Ca 
activity of the fish after 4 h exposure to Ca-containing water and 
2+ the mean SA of the water, and was normalized to fish weight. Ca 
efflux was calculated from the slope of the time curves of the Ca 
45 
appearance in the water and the mean Ca SA of the plasma and was 
normalized to fish weight. Flux is expressed in μπιοί per h per kg fish. 
2* Determination of branchial Ca influx. 
2+ Experimental procedures. To determine branchial Ca influx the 
isolated head preparation was used as described by Fayan & Matty (13), 
with some modifications according to Ferry & Wood (14). Procedures for 
2+ Ca influx calculation, and determination of transepithelial potential 
(TEF) have been described in detail recently by Verbost et al. (18). At 
the start of the experiment Ca (2.9 ι 10 6 Bq/litre) was added to the 
water. The Ringer solution was well aerated throughout the experiments. 
Product administration. CS crude tissue homogenates, hypocalcin, 
and residue proteins were added to the Ringer used to perfuse the 
gills. A 30 min perfusion with plain Ringers to determine control 
influx was followed by a 15 min perfusion with hormone containing 
Ringer, using separate containers connected by a three way valve. 
Hormone was added in concentrations of 50 pg/lOO ml Ringer for the 
isolated product, 100 yg/100 ml Ringer for residue proteins and 150 
pg/100 ml Ringer for crude tissue homogenate. 
Perfusate and water sampling. For Ca influx the Ca appearance 
rate in the perfusate collected from the dorsal aorta was determined 
(the dorsal aortic outflow represents 90-95% of the total Ca influx; 
14). Perfusate samples (100 μΐ) were taken every 1 min for the first 10 
min and every 5 min thereafter until t»30 min, followed by 10 one min 
intervals and a final 45 min sample. Water samples of 1 ml were taken 
at the same time. These samples were used to determine the water Ca 
SA. 
2+ Calculations. Ca influx was calculated on the basis of tracer 
appearance in the perfusate and the water Ca SA. Control influx was 
calculated at t-25-30 min; influx after hormone treatment was 
calculated at t-40-45 min. 
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Statistical analysis. 
Data are presented as mean values ± SEM. For statistical 
evaluation the Mann-Whitney U-test, one tailed, was used. Significance 
was accepted at Ρ < 0.05. 
RESULTS 
Whole body Ca2* fluì. 
2+ 
Controls. Ca influx values in untreated fish show only small 
variations for normal-calcium acclimated fish as well as for 
2 + low-calcium acclimated fish. No significant variation of Ca influx is 
observed over the two month period in which the experiments were 
performed. 
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Fig 1. Calcium influx (in), Ca 2 + efflux (out) and Ca 2 + net flux 
(hatched bars) for normal- and low-calcium acclimated fish. Mean values 
± SEM are given; number within the bars indicate n. Asterisks indicate 
significant difference from normal-calcium acclimated fish. 
Fig 2. Effects of CS crude homogenate, hypocalcin, and residue proteins 
on Ca influx (in) and Ca efflux (out) for nomal-саісішп acclimated 
fish. For efflux: control flux (c; fish without treatment) is given in 
the left side of the bars; experimental flux (e; fish after treatment) 
is indicated on the right sides of the bars. Hatched bars indicate Ca 
net flux. Mean values ± SEM are given; numbers within the bars indicate 
n. Asterisks indicate significant difference from the control. .sp 
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Law calcium acclimation. In Fig. 1 influx, efflux and net flux of 
calcium are shown for low-calcium acclimated fish and these are 
compared with flux values for normal-calcium acclimated fish. Under 
normal and low-calcium conditions net flux of calcium does not differ 
significantly, although both influx and efflux are lower in low-calcium 
acclimated trout. 
20 
10 
Ю 
Ftpmol-h^-kfl-M 
In 
'A 
Vi* •zzz 
UW ψυ 
ДО 
Out crud· г м М и · 
conlrcH hypocalcin 
Table 1 Effects of CS crude homo 
genate, hypocalcin and residue 
proteins on branchial Ca in 
flux (F l n). 
Fin (X) 
control 
crude 
hypocalcin 
residue 
92.7 ± 0.4 (4) 
80.6 ± 3.1 (4) * 
79.3 ± 2.7 (7) ** 
92.7 ± 4.1 (4) 
Mean values ± SEM are given in Ζ 
(η) of pre-hormone Ca influx 
(100 % came to 7.28 ± 1.13 μιηοΐ 
per hour per kg). Asterisks in­
dicate statistical significance 
( * Ρ < 0.014; ** Ρ < 0.003 ). 
Fig 3, Effects of CS crude homogenate, hypocalcin, and residue proteins 
on Ca influx (in) and Ca efflux (out) for low calcium acclimated 
fish. For efflux: control flux (c; fish without treatment) is given in 
the left side of the left side of the bars; experimental flux (e; fish 
after treatment) is indicated on the right side of the bars. Hatched 
bars indicate Ca net flux. Mean values ± SEM are given; numbers 
within the bars indicate n. Asterisks indicate significant difference 
from the control. 
Hormone effects. Figs. 2 and 3 show the effects of the various 
2+ 
treatments on the Ca in- and efflux values in normal and low-calcium 
acclimated fish compared to the controls (saline injected). Crude CS 
tissue homogenates and the isolated hypocalcin inhibit calcium influx 
in both groups. Similar doses of hypocalcin yield significantly greater 
inhibition in low-calcium acclimated trout than in normal-calcium 
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acclimated trout. Injection of the residue proteins (crude tissue 
2+ homogenate minus hypocalcin) do not affect Ca influx. 
CS crude tissue homogenates, hypocalcin, and residue proteins do 
2+ 
not alter Ca efflux compared to the saline treated or untreated fish 
2 + (Figs 2 and 3). Saline infusion (control "e") do not alter Ca efflux 
compared to untreated fish (control "c"; Figs 2 and 3). 
2+ Net Ca flux from the water in low and normal calcium acclimated 
trout are indicated by hatched bars in Figs 2 and 3. Injection of crude 
CS tissue homogenates and of hypocalcin, but not of the residue result 
2+ in a decrease of net Ca flux. Actually, fish show a net loss of 
calcium after injection of crude tissue homogenate as a result of the 
2+ decreased Ca influx. (2.0 and 1.55 μιαοί per hour per kg fish for 
normal and low-calcium acclimated fish, respectively). The same doses 
2+ 
of hypocalcin resulted in significantly greater inhibition of the Ca 
net flux in the low-calcium acclimated fish (97 X) than in the 
normal-calcium acclimated fish (52 TL). 
2+ 
Branchial Ca influx. 
Hormone effects. As shown in Table 1, crude tissue homogenates as 
well as isolated hormone, but not the residue proteins result in a 
2+ 
statistically significant decrease of branchial Ca influx in the 
isolated head preparation. For each fish the post-hormone treatment 
flux is expressed as a percentage of the pre-hormone treatment flux ( 
2+ 
-100 Z), because of the considerable variability in the values for Ca 
flux between individual fish. The average pre-treatment value was 7.2Θ 
±1.13 μπιοί per hour per kg fish (n-19; range 3.24 - 8.40 vmol/h/kg). 
Hormone and control injections did not affect the ТЕР. For the 
control, crude tissue homogenate, hypocalcin and residue treated fish 
the ТЕР was -0.05 ± 1.19, -1.62 ± 0.76, -0.65 ± 0.77 and -0.09 ± 0.39 
mV, respectively. The average value for all fish was -0.58 ± 0.70 mV. 
Treatment with crude tissue extracts resulted in an increase of 
systemic blood pressure of 20.3 ± 6.3 X. No blood pressure effects were 
observed in control-, hypocalcin- or residue-treated isolated head 
preparations (non detectable, 4.6 ± 2.8 and -1.0 ± 3.3 Z, 
respectively). 
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DISCUSSION 
The following conclusions are drawn from the data presented in 
this paper: 
In freshwater rainbow trout, hypocalcin, the 54 kDa glycoprotein 
isolated from the CS, inhibits Ca uptake from the water by inhibition 
of Ca^+ influx; Ca 2 + efflux is not affected. 
- Hypocalcin is more effective in fish acclimated to low-calcium water 
than in fish from normal-calcium water. 
2+ Hypocalcin also inhibits Ca influx in the isolated head 
preparation, thereby establishing the gill as an important target for 
hypocalcin. 
- Hypocalcin does not alter the branchial ТЕР; we suggest, therefore, 
2+ that the inhibition of Ca influx is due to a specific modulation of 
2+ the Ca uptake mechanism in the gill. 
2+ 2+ 
Our values for whole body Ca flux and branchial Ca flux 
2+ determined with the isolated head technique are in agreement with Ca 
flux values reported in the literature (3, S, 8, 13, 14, IS). Ve showed 
that hypocalcin, the 54 kDa product isolated from trout CS (Ch.3, 9) 
2+ inhibits whole body Ca uptake. Thus, the reduction of plasma calcium 
levels caused by injections of crude CS tissue homogenates observed in 
freshwater fish (21), at least in part, is the result of the hypocalcin 
2+ induced reduction of whole body Ca uptake. 
The inhibition of calcium influx by hypocalcin in adult trout was 
a consistent phenomenon in our study. Wagner et al. (20) reported that 
the hypocalcémie principle of salmon CS exerts inhibitory effects on 
Ca influx in juvenile rainbow trout, but only when basal Ca influx 
2+ in these fish is high (19). Our comparison of whole body Ca flux in 
2+ fish from normal-calcium and low-calcium water, with high and low Ca 
2+ influx rates, did not show such a relationship between Ca influx and 
the inhibitory effect of hypocalcin. 
We calculated that on protein basis four times more crude tissue 
extract than purified hormone was needed to obtain the same degree of 
2+ inhibition of whole body Ca* influx. This indicates that hypocalcin 
was purified from crude tissue extracts by a factor of about 4. This 
seems a rather low purification factor. It is, however, in good 
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agreement with the relatively large amount of hypocalcin present in 
crude tissue homogenates of CS of trout and eel when analysed by SDS-
polyacrylamide gel electrophoresis (about 12 Ζ on protein basis, Ch.3, 
9), and with the abundance of secretory granules observed in 
electronmicrographs of freshwater trout CS (Ch.3, 9, 22). 
In trout injections of hypocalcin inhibited branchial calcium 
influx but did not induce significant hypocalcemia within the 4 hour 
period of the flux determination. This may be expected since the net 
2+ 
whole body Ca flux from water to fish is still positive. After 
injection of crude tissue extracts a net loss of calcium is observed. 
Assuming an extracellular fluid volume of 300 ml/ kg body weight (8), a 
loss of θ pmol calcium as observed in a four hour period is only 1.3 % 
of the total calcium present in the extracellular fluid compartment of 
the fish and, therefore, may not be detectable at the level of a change 
in plasma calcium. The same dose of trout hypocalcin (6.5 fish 
equivalents), however, does evoke a hypocalcémie response in 15 days 
stanniectomised eels (Lafeber, unpublished results). 
In trout adapted to low-calcium water, the effect of hypocalcin 
2+ 
was more effective to inhibit Ca influx than in fish from 
normal-calcium water. This is consistent with observations of Wendelaar 
Bonga et al. (21), on killifish and tilapia. These authors showed that 
CS homogenates hardly influence plasma calcium levels in fish from 
normal-calcium freshwater. Conversely, significant hypocalcemia could 
be induced in fish from low-calcium freshwater. It was suggested that 
in low-calcium water the circulating levels of the active hypocalcémie 
principle of the CS will be low, which enables exogenous hormone to be 
more effective (21). This interpretation may also be applicable to our 
results. 
2+ 2+ 
We showed that both Ca influx and Ca efflux were lower in fish 
from low-calcium water than in fish from normal-calcium water, whereas 
total calcium uptake was similar in both groups. In this respect trout 
2+ differ from tilapia, in which increased Ca influx and efflux were 2+ 
reported, resulting in an increased Ca uptake, in low-calcium water 
(7). Apparently the control of calcium homeostasis is different in the 
two species. 
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The reduction of whole body Ca uptake by hypocalcin is caused by 
a specific inhibition of branchial Ca influx; whole body Ca' efflux 
is not effected. These results imply that the effect of hypocalcin on 
calcium extrusion via the kidney (1) must quantitatively be of less 
importance. It has been reported that calcium uptake by the gut is 
inhibited by hypocalcin (23). However, Ca' influx takes place for the 
larger part at the gill (A, 5) indicating the gill as an important 
target for hypocalcin. Therefore the relative contribution of the 
2+ 
control of hypocalcin on the intestinal Ca uptake will be of less 
2+ importance for the whole body Ca uptake. 
The inhibition of hypocalcin on gill calcium influx, as we 
observed in the isolated head, can account for the effect observed in 
vivo. In the isolated head 21 Ζ inhibition was obtained with SO μg/100 
ml Ringer. In the intact fish 52 X inhibition was obtained with 50 
pg/100 g body weight. Assuming that the hypocalcin distribution space 
in the fish is equivalent to the extracellular fluid volume (300 ml/kg 
body weight; 8) the in vivo dose of 50 μg/100 g body weight corresponds 
to a dose of 150 yg/100 ml extracellular fluid. These calcultions 
indicate that the in vivo to in vitro dosage ratio (0.42) is comparable 
to the in vivo to in vitro percentage inhibition ratio (0.35). Thus the 
inhibition of gill calcium uptake can be explained by the inhibition of 
branchial calcium uptake. This further substantiates indicates that the 
gill is an important target for hypocalcin. 
Since no pressor effects were observed with hypocalcin or residue 
proteins, we conclude that the increase in branchial vascular 
resistance is an effect specific for CS crude tissue extracts. The 
substance involved in pressure control must be smaller than 5 kDa (such 
small proteins are lost during ultrafiltration; Ch.3, 9) or inactivated 
during the isolation procedure, since no effect is observed after 
treatment with residue proteins. Chester Jones and coworkers had 
suggested already in 1969 the involvement of CS in vasopressor control 
(1). Apparently, hypocalcémie as well as vasoactive substances are 
present in the CS. 
Our data show that hypocalcin is involved in the inhibition of 
branchial uptake. But how does hypocalcin affect branchial calcium 
2+ flux? A model for branchial Ca uptake in freshwater trout has been 
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postulated by Ferry and Flik (IS). This model essentially corroborates 
2+ the model originally postulated for branchial Ca uptake in tilapia 
2+ (5, 6). In this model Ca uptake is thought to include a passive 
2+ 2+ 
apical Ca influx via calcium channels, and an active basolateral Ca 
2+ 
extrusion from the cytosol in the blood via a high affinity Ca 
2+ ATPase. In our studies on the hormonal control of branchial Ca uptake 
mechanism in freshwater fish, evidence is accruing, although no 
decisive answers can be given yet, that hypocalcin does not act on the 
2+ basolateral Ca ATPase. We therefore, hypothetize that the 
2+ hypocalcin-induced inhibition of branchial Ca influx involves 
modulation of calcium channels in the apical membranes of the calcium 
transporting cells. 
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Chapter 9 
EXPERIMENTAL HYPERCALCEMIA INDUCES HYPOCALCIN RELEASE 
AND INHIBITS BRANCHIAL Ca 2 + INFLUX IN FRESHWATER TROUT 
ABSTRACT 
Intravascular СаСІ2 infusion in freshwater rainbow trout (Salmo 
gairdneri) causes a significant degranulation of the corpuscles of 
Stannius (CS). Concurrently, there is a specific and acute inhibition 
2+ 2+ 
of whole body Ca influx; Ca efflux is unaffected. The material 
released consists primarily of a 2 kDa product which we identified as 
monomeric hypocalcin. Electron microscope observations of the CS reveal 
that type 1 and type 2 cells are degranulated to a similar extent. We 
conclude that hypocalcin is directly involved in hypocalcémie control 
2+ in freshwater fish via inhibition of branchial Ca influx, thereby 
2+ 
promoting a net loss of Ca across the gill. 
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INTRODUCTION 
Corpuscles of Stannius (CS) are small endocrine glands 
characteristic for holostean and teleostean fish. Rainbow trout usually 
have two to five corpuscles, located ventrocaudally to the kidney, that 
vary in diameter from 2 to 3 mm (1). More than the calcitonin secreting 
ultimobranchial glands, the CS are thought to be involved in 
hypocalcémie control in fish (see ref 2). 
In the literature, a variety of secretory products has been 
reported to be secreted by the CS (see 3-5). However, it has been 
demonstrated that the hypocalcémie product released by the CS is a 
glycoprotein (6, Ch.3, 7). We have recently isolated the glycoprotein 
from trout (Ch.3, 7), and call the principle hypocalcin, the name 
originally proposed by Fang et al. (8). Trout hypocalcin shows only 
small differences in molecular weight and substantial similarity in the 
N-terminal amino acid sequence when compared with the hypocalcémie 
principle of salmon, isolated by Wagner et al. (6), and eel isolated by 
Butkus and colleagues (9). 
There are indications that the CS of most euryhaline and 
freshwater fish species (such as trout), contain two structurally 
different cell types, viz type Í and type 2 cells (3, 10). Type 1 cells 
have been reported to respond to changes in the calcium concentration 
of the ambient water and thus are presumed to be the cells secreting 
the hypocalcémie principle. There is no consensus on the role of the 
type 2 cells although the regulation of electrolytes other than calcium 
has been attributed to this cell type (11, 12). However, some authors 
have suggested that both cell types are simply different physiological 
stages of one functional cell type (e.g. 13). 
Fish regulate their blood calcium levels efficiently (14, 15). 
They absorb calcium via the gills directly from the water and this 
uptake route accounts for most of their calcium requirement (16). 
Wagner et al. (б) showed that the salmon CS hypercalcémie principle 
decreases whole body Ca uptake in juvenile rainbow trout. Intra-
2+ 
arterial injections of homologous hypocalcin inhibits gill Ca influx 
in trout (Ch.8, 17). Although these data demonstrate the potential of 
hypocalcin to act as an hypocalcémie hormone, direct evidence for a 
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hypocalcémie function of endogenous hypocalcin is lacking. 
In this paper we report that experimentally induced hypercalcemia 
in freshwater rainbow trout results in a rapid degranulation of the CS 
cells, which coincides with a rapid and specific inhibition of whole 
2+ body Ca influx. These data, together with the results of our previous 
study (Ch.8, 17) that showed inhibition of branchial Ca^+ influx by 
hypocalcin injections, strongly suggest that hypocalcin indeed fulfills 
a hypocalcémie role in the calcium homeostasis of freshwater fish. 
MATERIALS AND METHODS 
Animals. 
Trout (Salmo gairdneri) used for whole body flux experiments (172 
± 5 g; n-35) were obtained from a commercial trout farm (Ontario, 
Canada). The fish were acclimated for at least 3 weeks to dechlorinated 
Ottawa city tap water containing (mM); Ca2+ (0.5), Cl" (0.1), Na+ 
(0.1), K+ (0.02). Our set up allowed a constant circulation of water 
through 1000 liter fibre glass tanks. Water temperature varied between 
10 and 12 *C and a pH between 7.0 and 7.4. The photoperiod was 12 hours 
of light alternating with 12 h of darkness. Fish were fed daily with a 
commercial trout diet. Fish were not fed 48 h before experimentation. 
Cannulation. Fish were anaesthetised in sodium bicarbonate 
buffered (pH 7.4) ethylaminobenzoate (MS222; 0.1 g/liter). During the 
surgery, that lasted up to 10 min, fish were kept moist and the gills 
were irrigated with water containing MS222. Dorsal aortic cannulation 
was performed using standard techniques. The cannula was secured to the 
roof of the buccal cavity with to Stiches and led out of the mouth 
through a perforation in the snout of the fish. When not used for blood 
sampling, the cannula was filled with slightly modified Cortland saline 
containing 10 U/ml ammonium heparin. Fish were allowed to recover for 
at least 24 hours prior to experimentation in individual opaque perspex 
flux boxes (volume - 3 1) supplied with flowing water. 
Experimental protocol. 
Calcium challenge. Trout were infused via a dorsal aorta cannula 
with 1 ml per 100 g fish of a 0.07 M СаСІ2 solution (t- -1 h). Infusion 
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of a NaCl solution of a similar osmolarity (0.12 M) served as control. 
In the СаСІ2 infused group, two blood samples (200 μΐ) were withdrawn 
before infusion and 10 blood samples (200 μΐ) were withdrawn at regular 
intervals over a 5 hours period after infusion. Blood samples were 
centrifugea and plasma was analysed for total calcium content. 
2+ NaCl and СаСІ2 infused fish were used for whole body Ca influx 
2+ 
and efflux determinations. Ca flux determinations were started 1 hour 
after the calcium infusion (t- 0 h) and lasted for 4 hours, upon 
completion of the experiment the CS were removed. A part of the glands 
was homogenized in 0.05 M ammonium acetate (pH 7.4) and prepared for 
SDS-FAGE (see below). Anothers part was prepared for electron 
microscope examinations. 
2* Determination of whole body Ca fluxes 
2+ Experimental procedures. Whole body Ca flux was determined on 
2+ 
cannulated fish kept in the flux boxes. At the start of a Ca influx 
45 
experiment, water flow through the flux box was discontinued and Ca 
was added to the water (5 ι 10 Bq/1; 1 h after СаСІ2 injection, t- 0 
h). Efficient mixing of the Ca with the water was assured by vigorous 
aeration of the water in the flux boxes. After a 4 hour exposure period 
the fish was killed with an overdose of MS222 (0. g/1; t- 4 h). Next 
the fish was rinsed in tap water (1 min) and transferred for 3 min to 
water containing 10 mM СаСІ2 to remove Ca adsorbed to integumental 
surfaces. To determine total body Ca activity, fish were microwave 
cooked (1.5 min) and homogenized in a commercial blender with 65X body 
weight of distilled water. Quintuple homogenate samples (approximately 
0.5 g weighed to the nearest 3 decimals) were dissolved at 60 "C 
overnight in 2 ml of tissue solubiliser (NCS, Amersham). Subsequently 
the samples were neutralized with glacial acetic acid; 5 ml of 
distilled water was added and the Ca content determined by liquid 
scintillation analysis (LSA). 
For Ca efflux experiments, fish were infused (via their cannula) 
24 h before the start of the flux period with 2.22 χ 106 Bq of 4 5Ca in 
1 ml of 0.6Ï NaCl. Ten min before the start of an experiment water flow 
through the boxes was discontinued and Ca appearance rate in the 
water monitored (see below). After a flux period of 4 hours, the Ca 
containing water was replaced by a flow of tracer free water until the 
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level of Ca had returned to background levels. This first flux 
2+ 
measurement served to determine control Ca efflux. Subsequently, fish 
were infused with a СаСІ2 solution or NaCl solution as described above, 
and this was followed after 1 hour by a second 4 h flux period; the 
second flux period was used to determine the effects of NaCl or СаСІ2 
2+ infusions on Ca efflux. 
Blood and water sampling. For influx as well as efflux 
measurements blood samples of 500 μΐ were taken via the catheter 
immediately before the start of the flux period (t- 0 h) and upon 
completion of the experiment (t- 4 h). For influx determinations, 5 ml 
water samples were taken 15 min after the start of the flux period, and 
at the end of the flux period (t- 4h). For efflux determinations water 
samples were taken at the start of the flux period, mid-way and at the 
end of the flux period (t-0, 2 and 4 h, respectively). Blood samples 
were centrifuged in heparinized tubes (1,5 ml; Eppendorf). Triplicate 
100 μΐ plasma samples and the 5 ml water samples were analysed for Ca 
2+ 
specific activity (SA). Influx of Ca was calculated on the basis of 
the total tracer content of the fish after 4 h exposure to Ca 
containing water and the mean specific activity of the water, and was 
2+ 
normalized to fish weight. Ca efflux was calculated from the slope of 
the time curves of tracer appearance in the water and the mean Ca SA 
of the blood plasma, normalized to fish weight, and expressed in цгаоіез 
per hour per kg fish. 
Analytical methods. 
The total calcium content of water and plasma was determined with 
a commercial calcium-kit (Sigma). Combined calcium-phosphate standard 
(Sigma) was used as a reference. 
Ca activity of water (5 ml) and plasma samples (100 μΐ plasma 
plus 4 ml of distilled water) was determined by LSA, after addition of 
10 ml of Scinti-Verse II (Fisher). 
Sodiumdodecylsulphate-polyacrylamide gel electrophorese (SDS-PAGE) 
was performed using Polyacrylamide slab-gels (15Z) run under reducing 
conditions, according to Laemmli (1Θ). After fixation of the proteins, 
the gels were silver-stained as described by Morrissey (19), 
quantification was performed by densitometric scanning. 
117 
CS were prepared for electron microscopy according to Wendelaar 
Bonga et al., (20). To discriminate between type 1 and type 2 cells 
ultrastructural criteria were used as described by Meats et al. (1) 
and Wendelaar Bonga et al. (20). Sections of CS of 5 different control 
(NaCl-infused) and experimental (CaClj-infused) fish were examined. 
Fifteen individual type 1 and type 2 cells were analysed per fish. 
Granule area as a fraction of cytoplasmic area was scored as a measure 
for granulation. 
Statistical evaluation. 
Data are presented as mean values ± SEM. For statistical 
evaluation the Mann-Whitney (/-test was used. Significance was accepted 
at Ρ < 0.05. 
RESULTS 
Shown in figure 1 the effects of СаСІ2 infusions on trout plasma 
calcium levels. Ten min after infusion a plasma calcium concentration 
of about 5 mM was reached. However, one hour after infusion plasma 
calcium levels had returned to 2.22 
1 0.07 mM, which is slightly, but 
significantly, above control values 
(1.73 ± 0.06 mM), and did not change 
significantly over the next 4 hour 
period (average value 2.31 ± 0.05 
mM), in which flux determinations 
were performed. 
Calcium (mM) 
Ϊ 
CaCI, 
'ьь.....
 r
..* 
(lux 
1 2 3 time(h) 
Fig 1. Plasma calcium concentrations 
in trout after СаСІ2 infusion (o), 
NaCl infusion (o). Mean values ± SEM 
are given; n-6. Bar indicates period 
of flux determinations. 
118 
Densitometrie scans of the silver-stained proteins present in CS 
tissue homogenates of fish infused with either NaCl (a) or СаСІ2 (b) is 
given in figure 2. CS of trout infused with calcium are specifically 
devoid of a protein with an apparent molecular weight of approximately 
2 kDa (gels run under reducing conditions). 
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Fig 2. Densitometrie scan of silverstained CS tissue homogenates of 
NaCl- and CaC^-infused fish after SDS-PAGE. Absorption is shown in % 
of maximum peak hight (underlined percentages refer to NaCl injection). 
Molecular weight (ш) of protein markers are given on the horizontal 
axis. Arrow indicates 26 kDa hypocalcin. 
Fig 3. Calcium influx and calcium efflux for NaCl and СаСІз infused 
fishj с - efflux before infusion, e - efflux after infusion. Hatched 
bars indicate net flux. Mean values ± SEM are given; numbers indicate 
n. Asterisk indicates statistically significant difference from NaCl-
infused fish. 
Figure 3 shows the effects of a calcium challenge on 
2+ 
unidirectional whole body Ca fluxes. A specific inhibition of calcium 
2+ influx was observed in the CaClj-infused fish; Ca efflux was not 
effected by calcium treatment. 
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Both, type 1 and type 2 cells of the CS had degranulated after 
СаСІ2 infusion (figure 1). Type 1 cells show a 52 I degranulatlon as 
compared to the controls; whereas type 2 cells show a 41 Ζ 
degranulatlon. 
Table 1. Effects of СаСІ2 infusions and NaCl infusions on the 
degree of granulation of the CS. 
treatment granulation (Z) 
type 1 cells type 2 cells 
NaCl 15.40 ± 1.14 2.02 ± 0.17 
СаСІ2 7.38 ± 0.72 * 1.20 ± 0.33 * 
Mean values ± SEM are given (n - 5). Asterisks indicate statis­
tically significant different from NaCl infused controls. Granula­
tion (at t - 4 h) is expressed as the percentage granule area of 
the cytoplasmic area. 
DICSUSSION 
Experimentally induced hypercalcemia in freshwater trout results 
in the release of hypocalcin by the CS, and a subsequent inhibition of 
2+ 2+ 
gill Ca influx, whereas Ca efflux is not effected. This results in 
a net loss of calcium from the fish. Plasma calcium levels are restored 
rapidly after CaClj injections: within one hour after injection plasma 
calcium levels are only slightly above control levels. It is unlikely, 
however, that this rapid decrease of plasma calcium is caused by the 
2+ 
observed inhibition of Ca influx. One may calculate from the data in 
fig 3 that the magnitude of net Ca loss (approximately 8 μmol/h/kg), 
and that this rate is too low to explain the plasma calcium decrease of 
1 mmol/h/kg observed in the first hour after СаСІ2 injection. The 
lattervalue is calculated from fig 1 assuming an extracellular fluid 
volume of 300 ml/kg fish; 21. It is likely, therefore, that the rapid 
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decrease in plasma calcium within the first hour after СаСІ2 injection 
is mainly due to equilibration with rapidly exchanging internal calcium 
pools, such as scales, bone and soft tissue (22). 
2+ Measurements of Ca fluxes in our control trout are in good 
agreement with recent studies on this species (Ch.8, 17, 23, 24). The 
2+ 
reduction of whole body Ca influx following СаСІ2 injection is a 
rapid response. This is in line with our assumption that this 
inhibition is mediated by hypocalcin, releaased upon the calcium 
2+ 
challenge: the reduction of Ca influx following injections of 
exogeneous hypocalcin is also an immediate effect that becomes 
noticable within a similar time span (Ch.8, 17). 
In the present study it was observed that degranulation of the CS 
results in the release of a product with an apparent molecular weight 
of 28 kDa. We have indentifled this product earlier as the reduced form 
of hypocalcin (Ch.3, 7). The secretion of this product seems 
specifically related to the increased plasma calcium concentration; 
magnesium or phosphate infusions do not induce the release of 
hypocalcin (unpublished observations). Whether this effect of increased 
plasma calcium levels on the release of hypocalcin is direct or 
indirect remains to be established. 
The concomitant degranulation of the CS cells and the specific 
2+ inhibition of Ca influx after experimentally induced hypercalcemia 
2+ leads us to conclude that hypocalcin modulates branchial Ca influx in 
the trout. The mechanisms involved in the hypocalcin-mediated 
2+ inhibition of Ca influx remain ill-defined. However, the rapidity of 
the effect excludes changes in the modulation of the amount of 
2+ branchial Ca -ATPase, and recent data (6. Flik, personal 
communication) fail to show effects of hypocalcin on the kinetic 
2+ properties of the Ca -ATPase. As suggested by Perry and Flik (24) and 
2+ Lafeber et al. (Ch.8, 17), the inhibition of Ca influx by hypocalcin 
most likely involves a decrease in apical membrane permeability in the 
calcium transporting cells of the gills, presumably by affecting apical 
membrane calcium channels (24). 
We feel that it is unlikely that heamodynamic adjustments 
2+ 
contribute to the reduced influx because Ca efflux is unaffected and 
hypocalcin does not affect perfusion pressure in an isolated trout head 
preparation (Ch.8, 17). 
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We show here that type 1 cells as well as type 2 cells of the 
corpuscles degranulate after СаСІ2 injection. Also Lopez and coworkers 
(13) concluded that both secretory cell types present in eel CS are 
degranulate after a six- to seven-fold increase of plasma calcium, 
induced by СаСІ2 injection. These authors concluded on the basis of 
light microscope observations that both types represent structurally 
different stages of one functional cell type. The size and number of 
the granules of the type 2 cells are such that these cells usually 
appear as non-stainable cells in the light microscope, and therefore 
ultrastructural examination seems a prerequisite for the study of 
degranulation of these cells. However, on the basis of our morphometric 
analysis we also conclude that the degree of degranulation is similar 
for both cell types. Several explanations are possible for this 
observation. 
First, it could be argued that the response of the CS cells (both 
type 1 and type 2 cells) to hypercalcemia is non-specific. It is well 
known that in many types of secretory cells granule release can be 
induced, at least in vitro, by a moderate increase of the calcium 
concentration of the ambient medium (25). Extremely high calcium 
levels, as induced in our experimental animals, usually lead to 
inhibition of glandular secretion (26, 27). In our experiments 
preliminary results showed no differences between the pituitary 
prolactin cells and the ultimobranchial C-cells of control and СаСІ2 
injected trout. In contrast, a marked degranulation was found in both 
types of CS cells. This response indicates a specific and direct 
relationship between the rates of secretion of both cell types and 
plasma calcium. 
An alternative explanation is that both cell types produce 
different hormones but share the specific response to hypercalcemia. To 
date, only one hormonal substance has been isolated from the CS (6, 
Ch.3, 7). The study of the biosynthesis of the CS in vitro revealed 
synthesis of only one major product with a molecular weight of 28 kDa 
(2 ) which has subsequently been shown to represent hypocalcin of the 
CS (Ch.3, 7). However, the small size and number of the granules of the 
type type 2 cells, when compared with the numerous large granules of 
the type 1 cells, reflect a low production of the secretory product of 
the type 2 cells. Therefore, it is possible that this product may not 
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be detected by biochemical analysis, and the possibility that both cell 
types produce different substances cannot be excluded. 
As a third explanation it could be debated that both cell types 
represent two structurally different subtypes or phases of the same 
functional cell type, which has been suggested before. On the basis of 
electron microscope studies the presence of two cell types, different 
in size and in the amount of and distribution of the secretory 
granules, was shown for the gold fish (29), guppy (30), Atlantic salmon 
(31), toadfish (32), and Coho salmon (33). It was suggested by these 
authors that the two cell types represent different structural stages 
of one functional cell type. However, physiological support for this 
suggestion has hardly been provided in any of these studies. On the 
other hand, several authors have reported that both cell types respond 
differently to changes in electrolyte concentrations of the ambient 
water (1, 11, 20, ЗА, 35), and it was proposed that they produce 
different hormones. Our observations represent the first 
ultrastructural evidence that both type 1 and type 2 cells respond to 
changes in plasma calcium. This urges a reinvestigation of the 
hypothesis that type 1 and type 2 cells are functionally similar. 
It could be that hypocalcémie substances other than those of the 
CS are secreted during experimentally induced hypercalcemia. In this 
respect, calcitonin should be mentioned. Ve feel that it is unlikely 
that increased release of calcitonin is responsible for the rapid 
2+ decrease of Ca influx after injections of СаСІ2. In general only 
minor effects (if any at all) of calcitonin on blood calcium levels in 
fish have been reported (see 2, 3). Moreover, recently Fenwick and co-
2+ 
workers were unable to show effects of calcitonin on Ca fluxes in the 
freshwater eel (personal communication). Contradictory results have 
been reported by Milet et al. (36). They showed an inhibitory effect of 
2+ 
calcitonin on Ca influx in isolated gill arches of the eel. However, 
2+ in these experiments an even greater stimulatory effect on Ca efflux 
was observed, an effect which we did not observe in our experiments. 
This makes it unlikely that the inhibition of Ca2 + influx we observed 
after СаСІ2 injections was mediated by calcitonin. 
In contrast to calcitonin, administration of CS extracts has 
consistently been reported to decrease plasma calcium levels (e.g. 3, 
12, Ch.8, 17). Furthermore, we recently observed a rapid decrease of 
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2+ 2+ 
Ca uptake after intravascular infusions of hypocalcln; Ca influx 
2+ 
was inhibited by about 80 Z, whereas Ca efflux was not effected 
(Ch.e, 17). The results are very similar to the effects of СаСІ2 
2+ infusion on the Ca fluxes observed in this paper. Therefore, it seems 
2+ likely that the decrease in Ca influx observed after an 
experimentally induced hypercalcemia results from the release of 
hypocalcln from the CS cells. 
In the first paragraph of the discussion we concluded that the 
2+ inhibition of Ca influx that occurred after СаСІ2 injections resulted 
2+ in a net efflux of Ca of approximately 8 pmol/h/kg. This is 
equivalent to a decrease of the total plasma calcium concentration with 
approximately 27 μΜ per hour (assuming an extracellular fluid volume of 
300 ml/kg fish). We ascribe this effect to the release of hypocalcln 
from the CS, and conclude than that the capacity of the CS to release 
hypocalcln seems sufficient for effective control of plasma calcium 
levels under physiological conditions. 
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SUMMARY AND DISCUSSION 
The relationship between the corpuscles of Stannius 
and the parathyroid glands 
PTH-like activity of hypocalcin 
The results presented in the Ch.2 and Ch.4 show that there is a 
striking similarity between the bone resorbing activity of hypocalcin 
and FTH in mouse calvarla. CS homogenates and hypocalcin evoked similar 
responses whereas residue proteins did not, from which we concluded 
that hypocalcin is responsible for the PTH-like activity of the CS 
extracts. 
Hypocalcin was able to increase bone resorption by the enhancement 
of osteoclastic activity. Approximately 430 times more hypocalcin than 
FTH was required to obtain a similar bone resorbing effect (Ch.4). 
Proceeding from this potency, the dose response curves for both 
hypocalcin and PTH were similar. Furthermore, no additive effect was 
observed when maximum stimulating concentrations hypocalcin and FTH 
were tested together. It is therefore likely, although no decisive data 
can be shown, that both hypocalcin and FTH act via the same receptor. 
This conclusion seems to be in contrast with the observation that 
hypocalcin is unable to stimulate the production of cAMF (Ch.4), 
because cAMF reportedly is an important second messenger in the PTH 
induced bone resorption (1). However, it has recently been found that 
the relation between PTH and cAMP is complicated. FTH-induced bone 
resorption Involves activation of osteoclasts by intervention of 
osteoblasts (2, 3). The mode of signalling from osteoblast to 
osteoclast remains to be elucidated. Activation of the osteoblast 
2+ involves increase of intracellular cAMP and Ca levels in these cells 
(4-6). The actions of both second messengers are interrelated, although 
either of them is able to induce bone resorption in vitro (7). Evidence 
has been obtained for the hypothesis that PTH induced bone resorption 
involves activation of an osteoblast receptor with two binding sites or 
two distinct receptors (Fig 1; 6-8). One of these receptor sites is 
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Fig 1. RI, receptor site which can be activated by PTH when the first 
two N-terminal amino acids are present; R2, receptor site activated by 
PTH when amino acid 3-34 are present and activated by hypocalcin (HC); 
Ν, guanine nucleotide regulatory unit; AC, adenylate cyclase; Ph.C, 
phospholipase-C; IP3, inositol-triphosphate; ER, endoplasmic reticulum; 
ob, osteoblast; oc, osteoclast. Ativation of both receptors results in 
a full physiological response in osteoblasts. At first cAMP production 
results in activation of the existing osteoclasts; subsequently, Ca 
activity results in recruitment of osteoclasts. Ca may be released 
from the endoplasmic reticulum by IP3 and/or may enter the cell via 
calcium channels in the outer membranei (modified after Löwick et al. 
1985 and Herrmann-Erlee et al. 1988.) 
activated by the N-terminal part of the PTH molecule (including the 
first 3 amino acids) and mediates adenylate cyclase activation. The 
other receptor site is thought to be activated by the C-terroinal part 
of PTH (including arainoacids 4-34) which leads to the activation of the 
2+ Ca second messenger pathway. The phospho-inositol metabolism 
(induction of inositol triphosphate by activation of phospholipase-C) 
2+ 
could be involved in activation of the Ca second messenger pathway 
(9). Involvement of guanine nucleotide regulatory proteins in this 
receptor second messenger system is suggested (10). 
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Surprisingly, PTH shortened or modified at the N-terminal part, 
e.g. PTH(3-34), does not effect cAMP production, but is still able to 
2+ induce bone resorption. This fragment was shown to act via Ca as a 
second messenger (6, 8). Since hypocalcin neither stimulates cAMP 
2+ production, it may also induce bone resorption via Ca as a second 
messenger. This hypothesis could indirectly be confirmed; hypocalcin 
increases the number of osteoclasts (Ch.2, 4) which is suggested to be 
2+ 
regulated through Ca functioning as a second messenger (8). These 
data suggest that hypocalcin could act via the same receptor as (N-
terrainal shortened) PTH in bone resorption, although direct evidence is 
still lacking. The observation that hypocalcin stimulates bone 
resorption in a PTH-like fashion but does not stimulate cAMP production 
makes hypocalcin an appropriate and interesting tool to investigate the 
bone resorbing mechanism and the relative contribution of both receptor 
sites. 
Hypocalcin-like activity of PTH 
Both hypocalcin and bovine PTH(l-84) show blood calcium lowering 
activity in STX eels (Ch.5). Equimolar concentrations of hypocalcin and 
PTH gave similar effects. This result corroborates previous results 
obtained in our laboratory which showed that bovine PTH(l-34) decreases 
plasma calcium levels in low calcium acclimated killifish and tilapia 
( П ) . 
Hypocalcin induces its hypocalcémie effect mainly by the 
inhibition of calcium uptake via the gills from the water (Ch.8). In 
2+ 
contrast, bovine PTH(l-34) was unable to inhibit whole body Ca uptake 
from the water (unpublished results). PTH(l-84) has not been tested 
yet. The absence of an inhibitory effect of PTH(l-34) might be 
explained by the supposition that the C-terminal part of PTH is 
essential to mimic the inhibitory effect of hypocalcin on whole body 
calcium uptake, whereas the N-terminal part evokes a hypocalcémie 
response different from the effect induced by hypocalcin. This 
hypothesis is supported by an observation reported in Ch.5: we showed 
that in hypocalcin treated fish the decrease in ionic calcium fully 
accounted for the decrease in total calcium, whereas in the PTH treated 
fish the decrease in total calcium exceeded the decrease in ionic 
calcium. This implies that PTH(l-84), in addition to the reduction of 
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blood ionic calcium, reduces the protein bound calcium fraction of the 
blood. In spite of this difference to hypocalcin, the similarity 
between the effects of hypocalcin and FTH in fish is remarkable. 
Comparison of hypocalcin and FTH 
There is not only a striking similarity in bioactivity between 
hypocalcin and FTH in fish: also the molar concentration of FTH that is 
required to obtain an effect in fish is comparable to that of 
hypocalcin (Ch.5). Moreover, although the potency of hypocalcin was low 
when compared to that of FTH in our bone resorption assay, the molar 
ratio of 430:1 that we found (Ch.4) compares well with e.g. the molar 
ratio of approximately 1000:1 reported for ovine prolactin in a fish 
prolactin bioassay (12, 13). What then is underlying this similarity in 
bioactivity? 
The hypothesis that the CS and parathyroids are homologous, as 
postulated by Lopez and colleagues (see ref 15), is no longer tenable. 
The homology has been questioned before (14) because both glands 
reportedly had a different embryologlcal origin, the renal mesoderm and 
the neural crest, respectively. However, the recent demonstration in 
the CS and the FTH glands of immunoreactivity to secretory protein I, a 
neural crest marker, indicates that the embryologlcal origin of both 
glands may indeed be similar (15). Nevertheless, the observation that 
the corpuscles of Stannius are confined to holostean and teleostean 
fish seems to exclude that the CS are phylogenetically related to the 
parathyroids. The terrestrial vertebrates have evolved from ancestral 
forms of the Sarcopterygii and not from the Actinopterygii to which 
the Holostei and Teleostei belong (16). 
Irrespective of the embryologlcal origin of both glands, the fact 
that hypocalcin and FTH have no similarity in primary structure 
contradicts the suggested homology between both calcium regulating 
glands. As discussed in chapter 3 and 4, the amino acid sequence as 
predicted from DMA structure of eel hypocalcin, and the N-terminal 
amino acid sequence of trout hypocalcin presented in chapter 3 show 
striking similarity with each other but not with FTH. Homology of the 
two hormones can therefore be excluded. 
It may be concluded that hypocalcin and FTH are a unique type of 
agonists. Hypocalcin mimics the effect of FTH and FTH mimics the effect 
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of hypocalcln. We therefore suggested that the similarity in 
bioactivity originates from a similarity in the three dimensional 
structure of both molecules (Ch.3). It is very interesting that two 
structurally unrelated peptides have similar bioactivity in fish as 
well as in mammalian test systems. It is known that unrelated molecules 
can evoke similar responses, e.g. morphines (alkaloids) mimic the 
effects of endogenous peptides, like endorphins and enkephalin, on the 
opiate receptors (17). It is, however, a unique and fascinating 
possibility that the ternary structure of two peptide hormones is 
responsible for similarity in bioactivity. 
Mechanisms involved in hypocalcémie control 
Hypocalcln and hypocalcémie regulation in freshvater fish 
Removal of the CS from eels resulted in a prolonged hypercalcemia, 
which was not corrected within at least 5 weeks (Ch.5). We concluded 
from this observation that the CS produce the main hypocalcémie hormone 
in these fish (Ch.7). Furthermore, experimentally induced hypercalcemia 
caused the release of hypocalcln from the CS and concurrently inhibited 
whole body calcium uptake (Ch.9). This effect on calcium uptake was 
very similar to the effect observed on whole body calcium uptake of 
fish that were injected intra-arterially with hypocalcln (Ch.8), which 
indicates that hypocalcln release under normal conditions will be 
evoked by elevated plasma calcium levels. 
Our data showed that the inhibition of whole body calcium uptake 
by hypocalcln was mainly caused by a decrease in gill calcium uptake 
(Ch.8). The calculated net loss of calcium caused by hypocalcin was 
sufficient to draw the conclusion that hypocalcin is a potent 
hypocalcémie hormone, with the gill as the most important target organ. 
This implies that hypocalcémie regulation in fish is mainly effected by 
modulation of the branchial exchange of calcium between the fish and 
the ambient water. It does not fully exclude an involvement of gut, 
kidney and bone in hypocalcémie regulation, but the contribution of 
these organs must be of minor importance in fresh water fish. On the 
other hand, the specific location of the CS on or in the kidneys and 
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the observation that the blood comming from the CS is drained via the 
kidneys (14) suggests that the kidneys are a target organ for some CS 
factor other than hypocalcin. It could be that the pressor activity 
that we found in a crude CS tissue homogenate and which could not be 
ascribed to hypocalcin (Ch.8), is exerted by an unknown substance 
produced by the CS that is involved in renal function, e.g. regulation 
of the glomular filtration rate (18). 
The mechanism of action of hypocalcin is distinctly different from 
that of calcitonin, the main hypocalcémie hormone of the terrestrial 
vertebrates. Although calcitonin is present in fish, and salmon 
calcitonin is used for anti-hypercalcemic treatment in clinical 
medicine, in fish calcitonin stimulates bone formation but is not 
directly involved in blood calcium regulation (19, 20). The function of 
calcitonin as a major hypocalcémie hormone probably developed after the 
water-to-land transition in vertebrate evolution, when the water was no 
longer available as a readily accessible calcium source and bone became 
important for calcium homeostasis of the body fluids. The function of 
calcitonin in calcium homeostasis may have evolved in conjunction with 
that of PTH, the homeostatic antagonist of hypocalcin in the 
terrestrial vertebrates. 
Hypocalcin inhibits branchial Ca uptake 
Hypocalcin is involved in short term inhibition of branchial Ca 
uptake. But how does hypocalcin effect branchial calcium uptake? A 
2+ 
model for branchial Ca uptake, as originally postulated for tilapia 
and subsequently modified for trout (Fig 2.), proposes a passive Ca 
entry along an electrochemical gradient from the water across the 
apical membrane of the chloride cells into the cytosol (21, 22). This 
2+ 2+ 
diffusive Ca influx, which is facilitated by the high Ca gradient 
over the apical membrane, was shown to occur via voltage-independent 
calcium channels (22). Calcium transition from the cytosol to the blood 
over the basolateral membrane of the chloride cells (an active process) 
2+ is reported to be achieved through a Ca ATPase pump mechanism. 
2+ Branchial Ca efflux on the other hand is thought to be a paracellular 
process controlled by the trans-epithelial potential (TEF) and the 
2+ 
chemical gradient for Ca between the extracellular fluid and the 
ambient water. 
135 
w 
Ca** 
; 
> 
ch 
am 
Fig 2. Model for branchial 
calcium uptake. BE, branchial 
epithelium; W, ambient water; 
B, blood; ef, extracellular 
fluid; am, apical membrane; bm, 
basolateral membrane; ch, Ca 
channel; tj, tight junction; 
HC, hypocalcin; Ca bp, calcium 
binding proteins. Hypocalcin 
activity (receptor activation 
and second messenger activity) 
results in blockage of apical 
calcium channels and a 
subsequent inhibition of 
branchial Ca2+ influx. (Model 
modified after Flik et al. 1985 
and Perry and Flik 1988). 
We hypothesize that hypocalcin acts by inhibition of the calcium 
entry into the chloride cells via an effect on the permeability of the 
apical membrane. The following arguments support this hypothesis. In 
2+ 
our calcium flux studies no effects were observed on Ca efflux, from 
which we conclude that hypocalcin does not effect the passive loss of 
2+ Ca (Ch.8, 9). This was supported by the fact that administration of 
hypocalcin did not influence the trans-epithelial potential across the 
2+ 
branchial epithelium (Ch.9). Branchial influx of Ca , however, was 
inhibited rapidly. On the basis of the model presented in figure 2, the 
2+ 
effect of hypocalcin on Ca influx can be due to either a direct 
2+ 
inhibition of the Ca transport ATPase in the basolateral membrane or 
an inhibition of the calcium entry at the apical membrane of the 
calcium transporting cells. The hypocalcin-induced inhibition of 
2+ branchial Ca influx might involve modulation of either the calcium 
channels at the apical membrane or the calcium pumps in the basolateral 
membranes, or both. The first possibility is the most likely one. 
Changes in the basolateral transport capacity by a change in the amount 
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2+ 
of transport Ca ATPase, e.g. by decreasing the number of cells or 
the amount of ATPase per cell, is unlikely within the time span of the 
experiment. Moreover, recently it has been found in our laboratory that 
2+ 
a direct inhibition of the basolateral Ca transport activity could 
not be established, whereas hypocalcin instantaneously inhibited the 
2+ influx of Ca in the branchial epithelial cells (Verbost, preliminary 
unpublished results). 
A model for endocrine calcium regulation 
The results presented in this thesis show that fresh water teleost 
fish possess a fast acting hypocalcémie control mechanism, which 
enables them, via the release of hypocalcin, to decrease quickly the 
uptake of calcium from the water. As shown in Ch.9, the final result of 
the release of hypocalcin may be a net loss of calcium. It should be 
kept in mind, however, that fresh water fish live in an environment 
with a calcium concentration slightly or well below that of the blood 
plasma. Since there is a passive loss of calcium (Ch.S) caused by 
outward diffusion across the gill epithelium one could argue that 
freshwater fish are facing a calcium shortage, unless the losses are 
compensated for by active calcium uptake. From this point of view the 
significance of hypocalcémie control mechanisms, and thus the 
functional importance of the CS, seems questionable. For growth and 
reproduction, and for compensation of the passive calcium losses a 
constant uptake of calcium from the environment is necessary. This 
seems to require hormones that promote calcium uptake, and any hormone 
inhibiting this process seems superfluous. What then is the function of 
the CS and of hypocalcin in freshwater fish? 
The supposition that freshwater fish are facing a calcium uptake 
shortage may be wrong. Although the calcium concentration of the blood 
plasma is higher than that of the water, the calcium concentration in 
the cytoplasm of the chloride cells separating the water from the blood 
is lower by at least two orders of magnitude (assuming that the 
roicromolar concentration present in the chloride cells is similar to 
the concentrations required for proper cell function in general). The 
2+ 
model for branchial Ca uptake as proposed above implies that calcium 
can enter the chloride cells passively. These cells are therefore at 
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risk of being incapacitated by excess calcium, unless the apical entry 
2+ 
of calcium is balanced by the basolaterally located Ca translocating 
mechanism. This leads to the conclusion that the control of the calcium 
uptake capacity across the branchial epithelium requires control of 
both the passive entry of calcium over the apical membrane as well as 
the active translocation of calcium across the basolateral membrane. 
We concluded above that hypocalcin controls the passive entry of 
calcium across the apical membrane. Prolactin is at least one of the 
hormones regulating the capacity of basolateral calcium translocation 
(23). However, this hormone seems less suitable for rapid modulation of 
the blood calcium level, since the effects of prolactin develop only 
slowly (24). The presence of a rapidly acting hypercalcémie hormone, 
possibly released from the pituitary gland, has been postulated, but 
not demonstrated so far (25, 26). 
We suggest that a rapidly acting hypercalcémie hormone is not 
necessary for the endocrine control of plasma calcium levels. The 
presence of a hypocalcémie hormone, hypocalcin, seems sufficient to 
maintain plasma calcium levels. This hypothesis is based on the 
assumption that calcium will enter the fish via the gills and thus 
create hypercalcemia unless the entry is inhibited by hypocalcin. As 
stated above, the calcium can enter the chloride cells of the gills 
passively, via the apical membrane, and will be subsequently 
transported from the cell to the blood via the basolateral calcium 
pump. This ATPase dependent transport, however, is calmodulin dependent 
as has recently been demonstrated in our laboratory (26). This implies 
that the calcium pump can be stimulated directly, without hormonal 
interference, by a rise in cytoplasmic calcium. Thus, increased 
2+ permeability of the apical cell membrane for Ca , through a reduction 
in circulating hypocalcin levels, will result in hypercalcemia. A 
specific and rapid hypercalcémie hormone is not necessary to explain 
the relatively high plasma calcium levels in fresh water fish. We 
hypothesise, therefore, that calcémie control is effected by the 
hypocalcémie mechanism alone. 
There is important evidence that supports this hypothesis, namely 
the excessive hypercalcemia that occurs after removal of the Stannius 
corpuscles. This phenomenon, for a long time not understood, is caused 
by an increase of the calcium uptake from the water (27). Apparently if 
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the passive calcium entry in the chloride cells is no longer restrained 
by hypocalcin, there is a lack of direct control of the calcium uptake 
from the water. This can be explained by assuming an overstimulation of 
the basolateral calcium transport mechanisms in the chloride cells due 
to chronically high intracellular calcium levels. Such a mechanism 
would lead to the rather paradoxical situation that a hypocalcémie 
hormone can be used for hypocalcémie as well as hypercalcémie control. 
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I) Vergelijking van hypocalclne en PTH in zoogdier en vis bioassays. 
Gewervelde landdieren zijn in staat het calciumgehalte van het 
bloed te reguleren binnen nauwe grenzen. Een tekort aan calcium in het 
bloed moet worden aangevuld omdat calcium voor veel processen van 
direct belang is (hypercalcemische regulatie). Een teveel aan calcium 
heeft daarentegen schadelijke gevolgen en moet daarom worden weggewerkt 
(hypocalcemische regulatie). Een goede afstemming van hypocalcemische 
en hypercalcemische regulatie leidt er toe dat het calciumgehalte in 
het bloed constant blijft (calciumhomeostase). 
Landdieren nemen calcium op via het voedsel en verliezen calcium 
met name via de urine. De opname van calcium via het voedsel verloopt 
niet continu. Een teveel aan opgenomen calcium moet worden opgeslagen 
om bij een tekort aan calcium in het bloed weer te worden afgegeven. 
Deze opslagplaats voor calcium wordt gevormd door het bot. Het hormoon 
calcitonine zorgt daarbij voor de opslag van calcium in het bot 
waardoor het calcium niveau in het bloed daalt. Daarentegen zorgt het 
bij schildklier hormoon (parathyroid hormoon, PTH) voor het vrijmaken 
van calcium uit het bot. Dit hormoon zorgt verder voor verhoging van 
het calcium gehalte in het bloed door de uitscheiding van calcium via 
de urine te verminderen en door de opname van calcium via de darm te 
stimuleren (indirect, via vitamine-D). 
Ook vissen reguleren calcium gehaltes in het bloed. Vissen nemen 
calcium echter niet of nauwelijks op via het voedsel, maar direct uit 
het water, via de kieuwen. Zij verliezen calcium via de urine en via de 
kieuwen. De kieuwen zijn voor vissen dus zowel van belang voor de 
ademhaling als voor het opnemen van calcium. Regulatie van de opname 
van calcium door de kieuwen en van de afgifte van calcium via kieuwen 
en nieren kan dus zorgen voor een constant calciumgehalte in het bloed. 
Omdat deze regulatie processen bij vissen continu kunnen plaatsvinden 
is een opslagplaats voor calcium, zoals bij landdieren, niet 
noodzakelijk. Bij de calciumregulatie van vissen zijn dan ook andere 
hormonen betrokken dan bij de landdieren. Prolactine en cortisoi zorgen 
voor een verhoogde opname van calcium door de kieuwen en remmen het 
verlies van calcium. Voor de hypocalcemische regulatie in vissen zorgen 
met name hormonen die worden gevormd en afgegeven door de lichaampjes 
van Stannius. 
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De lichaampjes van Stannius zijn onlangs bekend geworden doordat 
in de literatuur beschreven werd dat deze orgaantjes verwantschap 
vertonen met de bijschildklieren van de gewervelde landdieren. Antisera 
opgewekt tegen PTH bleken te reageren met producten uit de lichaampjes 
van Stannius. Verder bleken de producten uit de lichaampjes van 
Stannius in staat te zijn, evenals PTH, het calciumgehalte in het bloed 
van ratten te verhogen. Omgekeerd bleek PTH in staat te zijn het 
calciumgehalte in het bloed van vissen te verlagen, op dezelfde wijze 
als de producten van de lichaampjes van Stannius (Hoofdstuk 1). Het 
onderzoek beschreven in dit proefschrift heeft uitgaande van deze 
wetenschap geleid tot de volgende resultaten: 
Homogenaten van lichaampjes van Stannius en stoffen afgegeven door 
deze lichaampjes hebben dezelfde invloed als PTH op het vrijmaken van 
calcium uit het bot van muizen. Ook de botcellen betrokken bij het 
vrijmaken van calcium (Osteociasten,) worden net als door PTH, ook 
gestimuleerd door deze Stannius producten (Hoofdstuk 2). 
Bij een verhoging van het calciumgehalte in het bloed van de forel 
en de paling geven de lichaampjes van Stannius een eiwit af. Dit eiwit 
(een glycoprotein) is geïsoleerd uit een weefsel homogenaat van 
lichaampjes van Stannius waarbij gebruik is gemaakt van de suiker 
groepen die aan dit eiwit gebonden zijn (glycoprotein). Het product is 
hypocalcine genoemd, omdat het door de Stannius lichaampjes afgegeven 
wordt als reactie op een verhoging van het calciumgehalte van het 
bloed. De aminozuur-samenstelling van hypocalcine van de forel is 
bepaald en vertoont grote overeenkomsten roet de aminozuur samenstelling 
van hypocalcine van de zalm en de paling (Hoofdstuk 3). 
Hypocalcine blijkt de stof te zijn die verantwoordelijk is voor de 
overeenkomst in activiteit tussen homogenaten van de Stannius 
lichaampjes en PTH zoals beschreven in hoofdstuk 2. De werking van 
hypocalcine komt het meest overeen met PTH waarvan de eerste aminozuren 
zijn verwijderd. Dit N-terminaal gekorte PTH maakt calcium uit het bot 
van muizen vrij op eenzelfde manier als hypocalcine dit doet, via de 
2+ tussenkomst van Ca als intracellulaire boodschapper (Hoofdstuk A). 
PTH is net als hypocalcine in staat het calcium gehalte in het 
bloed van palingen -dat tevoren door verwijdering van de lichaampjes 
van Stannius (stanniectomle) sterk verhoogd is- te verlagen. Daarbij 
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blijkt dat met name de ionogene calcium fractie van het bloed wordt 
verlaagd (Hoofdstuk 5). 
Hypocalcine en PTH vertonen duidelijke overeenkomsten in 
activiteit. De aminozuur-samenstelling van PTH vertoont echter geen 
overeenkomst met de aminozuur-samenstelling van PTH. Een overeenkomst 
in de driedimensionale structuur van beide hormonen ligt daarom 
vermoedelijk ten grondslag aan de overeenkomst in activiteit. 
II) Onderzoek naar het workings mechanisme van hypocalcine. 
Omdat vissen calcium opnemen via de kieuwen en omdat de 
lichaampjes van Stannius betrokken zijn bij de hypocalcemische 
regulatie werd verondersteld dat hypocalcine de opname van calcium door 
de kieuwen zou remmen. De opname van calcium door de kieuwen vindt 
plaats door speciale cellen (chloride cellen) in de kieuwen. Calcium 
komt aan de waterkant de cell binnen (apicaal), gaat vervolgens door de 
chloride cel en gaat aan de de andere kant het bloed in (basolateraal). 
Omdat het calciumgehalte in de cel veel lager is dan in het water loopt 
calcium vanuit het water mogelijk via kanaaltjes in de apicale 
celmembraan (calcium channels) de cel in. In het bloed is het calcium 
gehalte echter veel hoger dan in de cel. Calcium zal dus vanuit de cel 
het bloed ingepompt moeten worden met behulp van een calcium 
transporterend enzym (Ca transport ATPase) (Hoofdstuk 6). Het 
onderzoek beschreven in het tweede deel van mijn proefschrift heeft 
uitgaande van deze wetenschap geleid tot de volgende resultaten: 
Het weghalen van de Stannius lichaampjes uit de paling zorgt er 
voor dat het calciumgehalte van het bloed stijgt en gedurende enkele 
weken sterk verhoogd blijft. Injectie van homogenaten van Stannius 
lichaampjes leidt tot een daling van het verhoogde calciumgehalte in 
deze vissen. Met name de ionogene fractie van het bloedcalcium blijkt 
door de lichaampjes van Stannnius te worden verlaagd (Hoofdstuk 7). 
Injectie van hypocalcine in forellen zorgt ervoor dat de opname 
van calcium door de kieuwen vermindert terwijl het verlies van calcium 
door de kieuwen onveranderd blijft. De remming van de opname van 
calcium door hypocalcine wordt toegeschreven aan het afsluiten van de 
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calcium kanalen in de apicale celmembraan van de chloride cellen 
(Hoofdstuk θ). 
De lichaampjes van Stannius hebben twee soorten cellen, type-1 en 
type-2 cellen. Door bij vissen het calciumgehalte in het bloed te 
verhogen kon worden aangetoond dat hypocalcine mogelijk wordt 
afgegeven, door beide celtypen. Dit afgegeven hypocalcine zorgt 
waarschijnlijk voor de remming van de opname van calcium uit het water 
die tegelijkertijd optreedt (Hoofdstuk 9). 
De resultaten uit de hoofdstukken 7, 8 en 9 hebben geresulteerd in 
een model voor de hormonale regulatie van de opname van calcium in 
zoetwater-vissen. Gesteld wordt dat zoetwater-vissen instaat zijn om 
uitsluitend met behulp van hypocalcine het calcium gehalte van het 
bloed te reguleren. Bij gewervelde landdieren zijn bij hetzelfde proces 
twee antagonistische functionerende hormonen betrokken: FTH en 
calcitonine. 
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Stellingen 
1) De inwaardse Ca gradient over de aplcale membraan van de Ca 
transporterende cellen in de kieuwen van zoetwatervissen Vorrat de basis 
voor de hypocalcerolsche controle bij deze dieren. 
Dit proefschrift 
2) Het gebruik van de benamingen "parathyrine" en "teleocalcine" voor 
het hormoon uit de lichaampjes van Stannius is niet langer te 
verdedigen. 
Contra: Tisserand-Jochem et al. Bone and Mineral 1987 2:163 
Wagner et al. 1986 Gen Comp Endocrinol 63:481 
3) De langdurige hypercalcémie na verwijdering van de hypocalcine 
producerende klieren in de paling duldt op de afwezigheid van 
functioneel vergelijkbare calclotrope hormonen. 
Dit proefschrift 
4) Het is onwaarschijnlijk dat de door Mllet et al. in vitro gemeten 
branchiale Ca fluxen in de paling een reële weergave vormen van de 
situatie in vivo. 
Mllet et al. 1980 С R Acad Sci 291:977 
5) Het in de literatuur veelvuldig gebruik van de term flux (mol/h/m') 
in plaats van flow (mol/h) voor whole body calcium bewegingen die 
worden uit gedrukt in μπιοΐ/h per kg vis is onjuist. 
6) De alkalische en zure fosfatasen in het serum van patiënten met een 
prostaatcarcinoom zijn van prognostische betekenis voor de 
overlevingsduur van de patient en de reactie van het prostaat carclnoom 
op hormonale therapie. 
Mulders et al. 1987 NTVG 32:1399 
7) De geringe kennis van het magnesium-metabolisme in vergelijking met 
het caleium-metabolisme is niet het resultaat van een geringere 
fysiologische betekenis van magnesium maar van de problematische 
productie van radioactief magnesium. 
8) Het feit dat mijn zoon kort na de geboorte zijn adem ingehouden zou 
hebben en naar de oppervlakte zou zijn komen drijven wanneer hij in het 
diepe gedeelte van het zwembad zou zijn 'gegooid' betekent niet dat hij 
biologisch gezien dicht bij de vissen zou staan. 
Contra: Little et al. Het babyboek voor vaders. Mondrla, Hazerswoude 



